NF-kappa	B-protein
B/Rel	I-protein
participation	O
in	O
the	O
lymphokine-dependent	O
proliferation	O
of	O
T	B-cell_type
lymphoid	I-cell_type
cells	I-cell_type
.	O

Proliferative	O
responses	O
of	O
lymphoid	B-cell_type
cells	I-cell_type
to	O
IL-2	B-protein
and	O
IL-4	B-protein
depend	O
on	O
activation	O
of	O
the	O
cells	O
,	O
but	O
the	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
activation	O
enhances	O
cellular	O
competence	O
to	O
respond	O
to	O
cytokines	B-protein
is	O
not	O
fully	O
understood	O
.	O

The	O
NF-kappaB/Rel	B-protein
family	I-protein
represents	O
one	O
signal	O
transduction	O
pathway	O
induced	O
during	O
such	O
activation	O
.	O

We	O
show	O
in	O
this	O
study	O
that	O
inhibition	O
of	O
NF-kappaB	B-protein
through	O
the	O
expression	O
of	O
an	O
IkappaBalpha	B-protein
(	O
inhibitory	B-protein
protein	I-protein
that	O
dissociates	O
from	O
NF-kappaB	B-protein
)	O
mutant	O
refractory	O
to	O
signal-induced	O
degradation	O
(	O
IkappaBalpha	B-protein
(	I-protein
DeltaN	I-protein
)	I-protein
)	O
interfered	O
with	O
the	O
acquisition	O
of	O
competence	O
to	O
proliferate	O
in	O
response	O
to	O
IL-4	B-protein
as	O
well	O
as	O
IL-2	B-protein
.	O

Thymocytes	B-cell_type
and	O
T	B-cell_type
cells	I-cell_type
from	O
IkappaBalpha	B-protein
(	I-protein
DeltaN	I-protein
)	I-protein
transgenic	O
mice	O
expressed	O
normal	O
levels	O
of	O
IL-2R	B-protein
subunits	I-protein
.	O

However	O
,	O
transgenic	B-cell_type
cells	I-cell_type
exhibited	O
a	O
dramatic	O
defect	O
in	O
Stat5A	O
activation	O
treatment	O
with	O
IL-2	B-protein
,	O
and	O
a	O
similar	O
defect	O
was	O
observed	O
for	O
IL-4	B-protein
-induced	O
Stat5	B-protein
.	O

In	O
contrast	O
,	O
T	B-cell_type
lymphoid	I-cell_type
cells	I-cell_type
with	O
inhibition	O
of	O
NF-kappaB	B-protein
showed	O
normal	O
insulin	O
receptor	O
substrate-2	O
phosphorylation	O
and	O
only	O
a	O
modest	O
decrease	O
in	O
Stat6	O
activation	O
and	O
insulin	O
receptor	O
substrate-1	O
phosphorylation	O
after	O
IL-4	O
stimulation	O
.	O

These	O
results	O
indicate	O
that	O
the	O
NF-kappaB/Rel/IkappaBalpha	O
system	O
can	O
regulate	O
cytokine	B-protein
receptor	I-protein
capacitation	O
through	O
effects	O
on	O
the	O
induction	O
of	O
downstream	O
signaling	O
by	O
the	O
Stat	B-protein
transcription	I-protein
factor	I-protein
family	I-protein
.	O

``	NULL
PDA	NULL
)	NULL
a-4-1BB	NULL
)	NULL
a-CTL	NULL
.	NULL

G	NULL
``	NULL
Th	NULL
VIVO	NULL
v	NULL
RE	NULL
SEAR	NULL
GCH	NULL
£	NULL
Discover	NULL
More	NULL
Me	NULL
Aﬁ	NULL
meJournal	NULL
a	NULL
EF-KBlkael	NULL
Participzhtion	NULL
in	NULL
tint	NULL
?	NULL

6T	NULL
ymphokine-Dependent	NULL
Proliferation	NULL
0	NULL
ImmunOIOgy	NULL
Lymphoid	NULL
Cells	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
__	NULL
ADA	NULL
L.	NULL
Mora	NULL
,	NULL
Jeehee	NULL
Youn	NULL
,	NULL
Achsah	NULL
D.	NULL
Keegan	NULL
and	NULL
Mark	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Boothby	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:2218-2227	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.4.2218	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/4/2218	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
80	NULL
articles	NULL
,	NULL
48	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/4/2218.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
NF	NULL
--	NULL
B/Rel	NULL
Participation	NULL
in	NULL
the	NULL
Lymphokine-Dependent	NULL
Proliferation	NULL
of	NULL
T	NULL
Lymphoid	NULL
Cells	NULL
!	NULL

Ana	NULL
L.	NULL
Mora	NULL
,	NULL
*	NULL
Jeehee	NULL
Youn	NULL
,	NULL
``	NULL
*	NULL
Achsah	NULL
D.	NULL
Keegan	NULL
,	NULL
``	NULL
and	NULL
Mark	NULL
Boothby®*	NULL
Proliferative	NULL
responses	NULL
of	NULL
lymphoid	NULL
cells	NULL
to	NULL
IL-2	NULL
and	NULL
IL-4	NULL
depend	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
activation	NULL
enhances	NULL
cellular	NULL
competence	NULL
to	NULL
respond	NULL
to	NULL
cytokines	NULL
is	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

The	NULL
NF-B/Rel	NULL
family	NULL
represents	NULL
one	NULL
signal	NULL
transduction	NULL
pathway	NULL
induced	NULL
during	NULL
such	NULL
activation	NULL
.	NULL

We	NULL
show	NULL
in	NULL
this	NULL
study	NULL
that	NULL
inhibition	NULL
of	NULL
NF-B	NULL
through	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
IxBa	NULL
(	NULL
inhibitory	NULL
protein	NULL
that	NULL
dissociates	NULL
from	NULL
NF-B	NULL
)	NULL
mutant	NULL
refractory	NULL
to	NULL
signal-induced	NULL
degradation	NULL
(	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
)	NULL
interfered	NULL
with	NULL
the	NULL
acquisition	NULL
of	NULL
competence	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
IL-2	NULL
.	NULL

Thymocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
IrxBa	NULL
(	NULL
AN	NULL
)	NULL
transgenic	NULL
mice	NULL
expressed	NULL
normal	NULL
levels	NULL
of	NULL
IL-2R	NULL
subunits	NULL
.	NULL

However	NULL
,	NULL
transgenic	NULL
cells	NULL
exhibited	NULL
a	NULL
dramatic	NULL
defect	NULL
in	NULL
Stat5A	NULL
activation	NULL
treatment	NULL
with	NULL
IL-2	NULL
,	NULL
and	NULL
a	NULL
similar	NULL
defect	NULL
was	NULL
observed	NULL
for	NULL
IL-4-induced	NULL
Stat5	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
lymphoid	NULL
cells	NULL
with	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
showed	NULL
normal	NULL
insulin	NULL
receptor	NULL
substrate-2	NULL
phosphorylation	NULL
and	NULL
only	NULL
a	NULL
modest	NULL
decrease	NULL
in	NULL
Stat6	NULL
activation	NULL
and	NULL
insulin	NULL
receptor	NULL
substrate-1	NULL
phosphorylation	NULL
after	NULL
IL-4	NULL
stimulation	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel/IxBa	NULL
system	NULL
can	NULL
regulate	NULL
cytokine	NULL
receptor	NULL
capacitation	NULL
through	NULL
effects	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
downstream	NULL
signaling	NULL
by	NULL
the	NULL
Stat	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
2218-2227.	NULL
ytokines	NULL
regulate	NULL
functions	NULL
in	NULL
lymphoid	NULL
cells	NULL
that	NULL
include	NULL
proliferation	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
differentiation	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Certain	NULL
responses	NULL
of	NULL
lymphocytes	NULL
to	NULL
cytokines	NULL
require	NULL
a	NULL
cellular	NULL
state	NULL
of	NULL
competence	NULL
that	NULL
is	NULL
acquired	NULL
only	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
lead	NULL
to	NULL
this	NULL
enhanced	NULL
responsiveness	NULL
are	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

Cells	NULL
may	NULL
not	NULL
respond	NULL
to	NULL
IL-2	NULL
,	NULL
a	NULL
growth	NULL
factor	NULL
for	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
unless	NULL
first	NULL
activated	NULL
so	NULL
that	NULL
the	NULL
IL-2Ra-chain	NULL
is	NULL
expressed	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

After	NULL
expression	NULL
of	NULL
the	NULL
full	NULL
high-affinity	NULL
IL-2R	NULL
triggered	NULL
by	NULL
engagement	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
IL-2	NULL
can	NULL
drive	NULL
responding	NULL
cells	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
inducing	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
an	NULL
autocrine	NULL
fashion	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
activation-induced	NULL
increases	NULL
in	NULL
IL-4Ra-chains	NULL
may	NULL
be	NULL
required	NULL
to	NULL
achieve	NULL
sufficient	NULL
IL-4	NULL
signaling	NULL
or	NULL
participate	NULL
in	NULL
growth	NULL
regulation	NULL
(	NULL
6-11	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
examples	NULL
of	NULL
receptor	NULL
induction	NULL
as	NULL
a	NULL
basis	NULL
for	NULL
competence	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
competence	NULL
of	NULL
a	NULL
cytokine	NULL
receptor	NULL
to	NULL
transduce	NULL
signals	NULL
may	NULL
be	NULL
regulated	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
may	NULL
not	NULL
be	NULL
sufficient	NULL
for	NULL
maximal	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
(	NULL
5	NULL
,	NULL
12-15	NULL
)	NULL
,	NULL
and	NULL
there	NULL
may	NULL
be	NULL
circumstances	NULL
under	NULL
which	NULL
T	NULL
cells	NULL
expressing	NULL
IL-4R	NULL
may	NULL
fail	NULL
to	NULL
activate	NULL
certain	NULL
signaling	NULL
events	NULL
normally	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

One	NULL
signaling	NULL
pathway	NULL
that	NULL
is	NULL
induced	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
regulates	NULL
cytokine-inducible	NULL
gene	NULL
expression	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
*Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
;	NULL
and	NULL
1immunology	NULL
Department	NULL
,	NULL
Holland	NULL
Labs	NULL
,	NULL
American	NULL
Red	NULL
Cross	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20855	NULL
Received	NULL
for	NULL
publication	NULL
July	NULL
11	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
November	NULL
17	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
The	NULL
Vanderbilt	NULL
Cancer	NULL
and	NULL
Diabetes	NULL
Research	NULL
and	NULL
Training	NULL
Centers	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA68485	NULL
and	NULL
P60	NULL
DK20593	NULL
)	NULL
through	NULL
core	NULL
functions	NULL
(	NULL
FACS	NULL
,	NULL
oligonucleotide	NULL
synthesis	NULL
)	NULL
and	NULL
a	NULL
Pilot	NULL
Project	NULL
(	NULL
DK20593	NULL
)	NULL
.	NULL

M.B	NULL
.	NULL

was	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
,	NULL
and	NULL
funding	NULL
for	NULL
this	NULL
work	NULL
was	NULL
provided	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
AI-36997	NULL
and	NULL
GM-42550	NULL
(	NULL
A.L.M	NULL
.	NULL

,	NULL
J.Y	NULL
.	NULL

,	NULL
and	NULL
M.B	NULL
.	NULL
)	NULL

and	NULL
Al-38985	NULL
(	NULL
A.D.K	NULL
.	NULL
)	NULL

)	NULL
.	NULL

2	NULL
Current	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Anatomy/Cell	NULL
Biology	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Han-yang	NULL
University	NULL
,	NULL
Seoul	NULL
,	NULL
Korea	NULL
.	NULL

°	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Mark	NULL
Boothby	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
AA-4214	NULL
M.	NULL
C.	NULL
N.	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-2363	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
mark.boothby	NULL
@	NULL
memail.vanderbilt.edu	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
involves	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
!	NULL

l	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
is	NULL
tightly	NULL
controlled	NULL
by	NULL
inhibitory	NULL
proteins	NULL
,	NULL
which	NULL
include	NULL
inhibitory	NULL
protein	NULL
that	NULL
dissociates	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
IxBa	NULL
)	NULL
.	NULL

*	NULL
The	NULL
noncovalent	NULL
association	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
dimers	NULL
with	NULL
these	NULL
inhibitory	NULL
molecules	NULL
prevents	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
NF-KB	NULL
proteins	NULL
in	NULL
lymphocytes	NULL
.	NULL

During	NULL
normal	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
IxBa	NULL
is	NULL
subject	NULL
to	NULL
sequence-specific	NULL
phosphorylation	NULL
and	NULL
ubiquitination	NULL
leading	NULL
to	NULL
IxBa	NULL
degradation	NULL
and	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-KB	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

We	NULL
have	NULL
developed	NULL
transgenic	NULL
(	NULL
Tg	NULL
)	NULL
mice	NULL
whose	NULL
T	NULL
lineage	NULL
expresses	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
,	NULL
an	NULL
IxBa	NULL
mutant	NULL
that	NULL
is	NULL
refractory	NULL
to	NULL
signal-induced	NULL
degradation	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
inhibition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
signaling	NULL
pathway	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
T	NULL
cell	NULL
proliferative	NULL
defect	NULL
refractory	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
phenotype	NULL
,	NULL
T	NULL
cells	NULL
lacking	NULL
the	NULL
individual	NULL
subunit	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
exhibited	NULL
an	NULL
impaired	NULL
proliferative	NULL
response	NULL
to	NULL
various	NULL
mitogens	NULL
despite	NULL
normal	NULL
production	NULL
of	NULL
IL-2	NULL
and	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggested	NULL
NF-	NULL
«	NULL
B/Rel	NULL
involvement	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
competence	NULL
to	NULL
generate	NULL
proliferative	NULL
responses	NULL
following	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
IL-2R	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
induction	NULL
of	NULL
competence	NULL
applies	NULL
to	NULL
cytokines	NULL
in	NULL
addition	NULL
to	NULL
IL-2	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
IL-4	NULL
is	NULL
a	NULL
cytokine	NULL
that	NULL
can	NULL
promote	NULL
the	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
T	NULL
lymphocytes	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

proteins	NULL
in	NULL
lymphokine-responsive	NULL
proliferation	NULL
of	NULL
T	NULL
lineage	NULL
cells	NULL
extends	NULL
to	NULL
a	NULL
different	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
,	NULL
we	NULL
have	NULL
measured	NULL
the	NULL
responses	NULL
to	NULL
IL-4	NULL
of	NULL
cells	NULL
derived	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
and	NULL
investigated	NULL
mechanisms	NULL
for	NULL
altered	NULL
IL-2-	NULL
and	NULL
IL-4-dependent	NULL
proliferation	NULL
to	NULL
determine	NULL
whether	NULL
there	NULL
are	NULL
any	NULL
lympho-kine-specific	NULL
differences	NULL
underlying	NULL
the	NULL
hyporesponsiveness	NULL
to	NULL
these	NULL
cytokines	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Mice	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
,	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
a	NULL
frans-dominant	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factors	NULL
is	NULL
targeted	NULL
specifically	NULL
to	NULL
the	NULL
T	NULL
lincage	NULL
*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
IB	NULL
,	NULL
inhibitory	NULL
protein	NULL
that	NULL
dissociates	NULL
from	NULL
NF-KB	NULL
;	NULL
IRS	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate	NULL
;	NULL
Jak	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
NTg	NULL
,	NULL
nontransgenic	NULL
;	NULL
Tg	NULL
,	NULL
trans-genic	NULL
;	NULL
y	NULL
,	NULL
,	NULL
common	NULL
y-chain	NULL
;	NULL
Chi	NULL
,	NULL
chimeric	NULL
.	NULL

0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
using	NULL
the	NULL
proximal	NULL
Ick	NULL
promoter	NULL
and	NULL
cointegration	NULL
of	NULL
a	NULL
CD2	NULL
locus	NULL
control	NULL
region	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
selected	NULL
experiments	NULL
,	NULL
these	NULL
mice	NULL
were	NULL
crossed	NULL
with	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
Ick	NULL
proximal	NULL
promoter	NULL
alone	NULL
leads	NULL
to	NULL
T	NULL
cell-specific	NULL
expression	NULL
of	NULL
a	NULL
transgene	NULL
encoding	NULL
a	NULL
chimeric	NULL
cytokine	NULL
receptor	NULL
in	NULL
which	NULL
the	NULL
mouse	NULL
extracellular	NULL
and	NULL
transmem-brane	NULL
domains	NULL
are	NULL
fused	NULL
to	NULL
a	NULL
mouse	NULL
IL-4Ra	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
26	NULL
)	NULL
.	NULL

All	NULL
mice	NULL
were	NULL
maintained	NULL
in	NULL
specific	NULL
pathogen-free	NULL
conditions	NULL
using	NULL
microisolator	NULL
cages	NULL
and	NULL
were	NULL
used	NULL
at	NULL
6-8	NULL
wk	NULL
of	NULL
age	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
federal	NULL
and	NULL
state	NULL
government	NULL
regulations	NULL
after	NULL
institutional	NULL
approval	NULL
.	NULL

Cell	NULL
preparations	NULL
Single	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
from	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
by	NULL
crushing	NULL
the	NULL
organs	NULL
in	NULL
complete	NULL
media	NULL
(	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
penicillin-strepto-mycin	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
hypotonic	NULL
lysis	NULL
of	NULL
erythrocytes	NULL
.	NULL

Splenic	NULL
and	NULL
lymph	NULL
node	NULL
T	NULL
lymphocytes	NULL
were	NULL
depleted	NULL
of	NULL
B	NULL
cells	NULL
by	NULL
chromatography	NULL
through	NULL
nylon	NULL
wool	NULL
columns	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
single	NULL
cell	NULL
suspensions	NULL
from	NULL
pooled	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
were	NULL
loaded	NULL
onto	NULL
nylon	NULL
wool	NULL
columns	NULL
preequlibrated	NULL
with	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FBS	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
45	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
nonadherent	NULL
cells	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
columns	NULL
.	NULL

The	NULL
resultant	NULL
population	NULL
was	NULL
<	NULL
10	NULL
%	NULL
B220+*	NULL
and	NULL
75-90	NULL
%	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Proliferation	NULL
assays	NULL
Thymocyte	NULL
suspensions	NULL
were	NULL
counted	NULL
and	NULL
plated	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
100	NULL
ul	NULL
of	NULL
media	NULL
)	NULL
in	NULL
microtiter	NULL
wells	NULL
.	NULL

Triplicate	NULL
samples	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml1	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
PMA	NULL
and	NULL
IL-4	NULL
,	NULL
PMA	NULL
and	NULL
IL-2	NULL
,	NULL
PMA	NULL
and	NULL
IL-12	NULL
,	NULL
or	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Tritiated	NULL
thymidine	NULL
(	NULL
1	NULL
uCi	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
media	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
for	NULL
the	NULL
final	NULL
8	NULL
h	NULL
before	NULL
determination	NULL
of	NULL
radioisotope	NULL
incorporation	NULL
into	NULL
DNA	NULL
.	NULL

T	NULL
lymphocyte	NULL
preparations	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
node	NULL
,	NULL
depleted	NULL
of	NULL
B	NULL
cells	NULL
as	NULL
described	NULL
above	NULL
,	NULL
were	NULL
plated	NULL
in	NULL
microtiter	NULL
wells	NULL
previously	NULL
incubated	NULL
overnight	NULL
with	NULL
PBS	NULL
or	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
10	NULL
ug/ml	NULL
,	NULL
clone	NULL
2C11	NULL
;	NULL
PharMingen	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Triplicate	NULL
samples	NULL
were	NULL
then	NULL
cultured	NULL
(	NULL
48	NULL
h	NULL
at	NULL
37°C	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
an	NULL
activating	NULL
mAb	NULL
against	NULL
CD28	NULL
(	NULL
10	NULL
pg/ml	NULL
,	NULL
clone	NULL
37.51	NULL
;	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
anti-CD28	NULL
and	NULL
IL-2	NULL
,	NULL
or	NULL
anti-€CD28	NULL
and	NULL
IL-4	NULL
,	NULL
or	NULL
as	NULL
for	NULL
thymocytes	NULL
,	NULL
as	NULL
indicated	NULL
;	NULL
DNA	NULL
synthesis	NULL
was	NULL
then	NULL
quantified	NULL
as	NULL
above	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
single	NULL
cell	NULL
suspensions	NULL
of	NULL
thymocytes	NULL
or	NULL
T	NULL
cells	NULL
using	NULL
high-salt	NULL
extraction	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
in-hibitors	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
then	NULL
used	NULL
for	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
NF-B/Re	NULL
!	NULL

proteins	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
was	NULL
a	NULL
double-stranded	NULL
P-labeled	NULL
oligonucleotide	NULL
modified	NULL
from	NULL
a	NULL
«	NULL
B	NULL
enhancer	NULL
sequence	NULL
in	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
«	NULL
B-pd	NULL
)	NULL
(	NULL
5-CAACGGCAGGG	NULL
GAATTCCCCTCTCCTT-3	NULL
'	NULL
)	NULL
.	NULL

DNA-binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
20	NULL
1	NULL
)	NULL
contained	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
2	NULL
ug	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
BSA	NULL
buffered	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
DTT	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
were	NULL
then	NULL
resolved	NULL
on	NULL
a	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
Stat5-	NULL
and	NULL
Stat6-binding	NULL
activities	NULL
,	NULL
thymocytes	NULL
or	NULL
B	NULL
cell-depleted	NULL
T	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
overnight	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
or	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
and	NULL
anti-CD28	NULL
(	NULL
2.5	NULL
pg/ml	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
then	NULL
rinsed	NULL
once	NULL
with	NULL
RPMI	NULL
medium	NULL
without	NULL
serum	NULL
,	NULL
cultured	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
serum-free	NULL
media	NULL
,	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
medium	NULL
alone	NULL
,	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.4	NULL
mM	NULL
PMSF	NULL
,	NULL
3	NULL
mg/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
of	NULL
insoluble	NULL
material	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
%	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

For	NULL
the	NULL
EMSA	NULL
,	NULL
cell	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
30	NULL
min	NULL
with	NULL
P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
Stat	NULL
binding	NULL
sites	NULL
,	NULL
then	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
nondenaturing	NULL
4.5	NULL
%	NULL
PAGE	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
contained	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
Stat5	NULL
(	NULL
upper	NULL
strand	NULL
,	NULL
5-AGATITCTAGGAATTCAATCC	NULL
3	NULL
'	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
a	NULL
Stat6	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
mouse	NULL
germline	NULL
epsilon	NULL
Ig	NULL
heavy	NULL
chain	NULL
promoter	NULL
(	NULL
5-AACTTC	NULL
CCAAGAACAGA-3	NULL
``	NULL
)	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
Single	NULL
cell	NULL
suspensions	NULL
of	NULL
thymocytes	NULL
treated	NULL
overnight	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/m	NULL
!	NULL
)	NULL

,	NULL
or	NULL
T	NULL
cells	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
node	NULL
treated	NULL
with	NULL
anti-CD3	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
anti-CD28	NULL
(	NULL
2.5	NULL
pg/ml	NULL
)	NULL
were	NULL
incu-	NULL
2219	NULL
bated	NULL
with	NULL
fluorochrome-conjugated	NULL
or	NULL
biotinylated	NULL
Abs	NULL
(	NULL
PharMingen	NULL
)	NULL
against	NULL
IL-2Ra/CD25	NULL
(	NULL
FITC	NULL
)	NULL
,	NULL
y-chain	NULL
(	NULL
biotin	NULL
)	NULL
,	NULL
IL-2RB/CD122	NULL
,	NULL
or	NULL
IL-4Ra	NULL
(	NULL
biotin	NULL
)	NULL
at	NULL
4°C	NULL
,	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

CD122	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
three-step	NULL
staining	NULL
,	NULL
including	NULL
biotinylated	NULL
goat	NULL
anti-rat	NULL
Ig	NULL
and	NULL
streptavidin-PE	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
Whole	NULL
cell	NULL
extracts	NULL
obtained	NULL
from	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
pooled	NULL
splenic	NULL
and	NULL
lymph	NULL
node	NULL
cells	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
antisera	NULL
against	NULL
Stat5A	NULL
,	NULL
Stat5B	NULL
(	NULL
Zymed	NULL
Laboratories	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate-1	NULL
(	NULL
IRS-1	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
and	NULL
IRS-2	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
precipitates	NULL
were	NULL
washed	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
solubilized	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
resolved	NULL
on	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
probed	NULL
in	NULL
accordance	NULL
with	NULL
manufacturer	NULL
's	NULL
protocols	NULL
using	NULL
mAbs	NULL
against	NULL
phosphotyrosine	NULL
(	NULL
RC-20	NULL
;	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
;	NULL
and	NULL
4G10	NULL
;	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
,	NULL
StatSA	NULL
,	NULL
Stat5B	NULL
,	NULL
IRS-1	NULL
,	NULL
or	NULL
IRS-2	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
rinsing	NULL
with	NULL
PBS-0.1	NULL
%	NULL
Tween	NULL
,	NULL
bound	NULL
Abs	NULL
were	NULL
detected	NULL
using	NULL
enhanced	NULL
chemiluminescence	NULL
and	NULL
secondary	NULL
Abs	NULL
,	NULL
where	NULL
indicated	NULL
(	NULL
NEN	NULL
,	NULL
Dupont	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
analysis	NULL
of	NULL
RNA	NULL
Suspensions	NULL
of	NULL
thymocytes	NULL
and	NULL
B	NULL
cell-depleted	NULL
T	NULL
cells	NULL
were	NULL
plated	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
and	NULL
cultured	NULL
overnight	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
PMA	NULL
and	NULL
IL-4	NULL
,	NULL
or	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
thymocytes	NULL
,	NULL
or	NULL
with	NULL
IL-4	NULL
and	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
for	NULL
T	NULL
cells	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
TRIzol	NULL
reagent	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

After	NULL
resolving	NULL
RNAs	NULL
by	NULL
electrophoresis	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
,	NULL
nucleic	NULL
acids	NULL
were	NULL
transferred	NULL
to	NULL
Nylon	NULL
membranes	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
fixed	NULL
by	NULL
UV	NULL
cross-linking	NULL
,	NULL
then	NULL
probed	NULL
using	NULL
cDNAs	NULL
labeled	NULL
by	NULL
random	NULL
hexamer	NULL
priming	NULL
and	NULL
hybridization	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
,	NULL
0.6	NULL
M	NULL
NaCl	NULL
,	NULL
4X	NULL
Denhardt	NULL
's	NULL
,	NULL
50	NULL
ug/ml	NULL
sheared	NULL
,	NULL
denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
5	NULL
%	NULL
dextran	NULL
sulfate	NULL
at	NULL
42°C	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
in	NULL
2X	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
then	NULL
in	NULL
0.5	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
60°C	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
RNAs	NULL
was	NULL
verified	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
and	NULL
by	NULL
hybridization	NULL
with	NULL
a	NULL
rRNA	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Band	NULL
intensities	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
Fuji	NULL
BAS	NULL
1000	NULL
phosphor	NULL
imager	NULL
.	NULL

Results	NULL
Role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
in	NULL
IL-4-dependent	NULL
proliferation	NULL
of	NULL
T	NULL
lymphoid	NULL
cells	NULL
We	NULL
previously	NULL
reported	NULL
that	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
mice	NULL
expressing	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
signaling	NULL
(	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
)	NULL
proliferated	NULL
poorly	NULL
after	NULL
mitogenic	NULL
stimuli	NULL
,	NULL
and	NULL
that	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
did	NULL
not	NULL
reverse	NULL
this	NULL
abnormality	NULL
(	NULL
21	NULL
)	NULL
.	NULL

These	NULL
data	NULL
were	NULL
interpreted	NULL
as	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
defect	NULL
refractory	NULL
to	NULL
IL-2	NULL
,	NULL
but	NULL
it	NULL
was	NULL
unclear	NULL
whether	NULL
receptor	NULL
expression	NULL
was	NULL
diminished	NULL
or	NULL
whether	NULL
activation	NULL
of	NULL
specific	NULL
signaling	NULL
pathways	NULL
downstream	NULL
from	NULL
the	NULL
IL-2R	NULL
was	NULL
affected	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
.	NULL

As	NULL
outlined	NULL
above	NULL
,	NULL
it	NULL
seemed	NULL
possible	NULL
that	NULL
the	NULL
findings	NULL
were	NULL
due	NULL
to	NULL
an	NULL
inability	NULL
of	NULL
activating	NULL
signals	NULL
to	NULL
create	NULL
a	NULL
state	NULL
of	NULL
competence	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B/Rel	NULL
!	NULL

l	NULL
signaling	NULL
is	NULL
required	NULL
for	NULL
responses	NULL
of	NULL
T	NULL
lymphoid	NULL
cells	NULL
to	NULL
any	NULL
other	NULL
lymphokine	NULL
,	NULL
we	NULL
measured	NULL
proliferative	NULL
responses	NULL
to	NULL
IL-4	NULL
using	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
and	NULL
their	NULL
wild-type	NULL
lit-termates	NULL
(	NULL
nontransgenic	NULL
(	NULL
NTg	NULL
)	NULL
mice	NULL
)	NULL
.	NULL

The	NULL
proliferative	NULL
response	NULL
to	NULL
IL-4	NULL
of	NULL
PMA-treated	NULL
thymocytes	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
was	NULL
one-tenth	NULL
that	NULL
of	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
proliferative	NULL
defect	NULL
was	NULL
observed	NULL
using	NULL
cells	NULL
cultured	NULL
in	NULL
PMA	NULL
and	NULL
IL-2	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
4-fold	NULL
difference	NULL
between	NULL
NTg	NULL
and	NULL
Tg	NULL
samples	NULL
stimulated	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
21	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
legend	NULL
)	NULL
.	NULL

As	NULL
ex-pected	NULL
,	NULL
thymocytes	NULL
did	NULL
not	NULL
proliferate	NULL
appreciably	NULL
when	NULL
treated	NULL
with	NULL
PMA	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-4	NULL
alone	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
PMA	NULL
was	NULL
required	NULL
to	NULL
induce	NULL
thymocyte	NULL
competence	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
or	NULL
IL-4	NULL
,	NULL
and	NULL
that	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

signaling	NULL
was	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
this	NULL
competent	NULL
state	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
a	NULL
similar	NULL
requirement	NULL
applies	NULL
to	NULL
mature	NULL
T	NULL
cells	NULL
,	NULL
proliferative	NULL
responses	NULL
to	NULL
IL-2	NULL
and	NULL
IL-4	NULL
were	NULL
measured	NULL
using	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
2220	NULL
NF-	NULL
«	NULL
B	NULL
AND	NULL
LYMPHOKINE-DEPENDENT	NULL
PROLIFERATION	NULL
OF	NULL
T	NULL
LYMPHOID	NULL
CELLS	NULL
A	NULL
Thymus	NULL
304	NULL
204	NULL
§	NULL
%	NULL
101	NULL
&	NULL
_	NULL
o	NULL
g	NULL
?	NULL

0	NULL
-	NULL
PMA	NULL
lone	NULL
2	NULL
4	NULL
2	NULL
4	NULL
£	NULL
8	NULL
28°	NULL
PMA	NULL
o	NULL
W.T	NULL
.	NULL

Iz	NULL
B	NULL
T	NULL
cells	NULL
m	NULL
To	NULL
2	NULL
*	NULL
60	NULL
pal	NULL
T	NULL
404	NULL
204	NULL
04	NULL
0	NULL
0	NULL
2	NULL
4	NULL
0	NULL
2	NULL
4	NULL
0	NULL
2	NULL
4	NULL
anti-CD3	NULL
anti-CD3	NULL
PMA	NULL
anti-CD28	NULL
C	NULL
W.T	NULL
.	NULL

1g	NULL
PMA	NULL
oo	NULL
eee	NULL
lono	NULL
+	NULL
-	NULL
%	NULL
%	NULL
=	NULL
#	NULL
FIGURE	NULL
1	NULL
.	NULL

IxBa	NULL
(	NULL
AN	NULL
)	NULL
inhibition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

pathway	NULL
impairs	NULL
the	NULL
competence	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
IL-4	NULL
growth	NULL
signaling	NULL
.	NULL

A	NULL
,	NULL
Thymocytes	NULL
from	NULL
either	NULL
NTg	NULL
(	NULL
]	NULL
)	NULL
or	NULL
Tg	NULL
(	NULL
MB	NULL
)	NULL
I	NULL
<	NULL
Ba	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
were	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
pulsed	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
with	NULL
tritiated	NULL
thymidine	NULL
and	NULL
harvested	NULL
for	NULL
scintillation	NULL
counting	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
tritiated	NULL
thymidine	NULL
incorporation	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
pooled	NULL
thymocytes	NULL
from	NULL
six	NULL
NTg	NULL
and	NULL
eight	NULL
Tg	NULL
mice	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

Thymidine	NULL
incorporation	NULL
into	NULL
these	NULL
pooled	NULL
thymocytes	NULL
treated	NULL
was	NULL
21,521	NULL
cpm	NULL
(	NULL
Tg	NULL
)	NULL
compared	NULL
with	NULL
91,947	NULL
cpm	NULL
(	NULL
NTg	NULL
)	NULL
when	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

B	NULL
,	NULL
B	NULL
cell-depleted	NULL
T	NULL
cells	NULL
prepared	NULL
from	NULL
pooled	NULL
lymph	NULL
nodes	NULL
and	NULL
spleens	NULL
of	NULL
Tg	NULL
and	NULL
NTg	NULL
mice	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
,	NULL
using	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
10	NULL
pg/m	NULL
!	NULL

l	NULL
)	NULL
,	NULL
agonistic	NULL
Abs	NULL
against	NULL
CD28	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
each	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Tritiated	NULL
thymidine	NULL
incorporation	NULL
was	NULL
determined	NULL
as	NULL
in	NULL
A	NULL
.	NULL

C	NULL
,	NULL
Gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B/Rel	NULL
pro-teins	NULL
.	NULL

Pooled	NULL
thymocyte	NULL
suspensions	NULL
were	NULL
prepared	NULL
from	NULL
six	NULL
NTg	NULL
and	NULL
eight	NULL
Tg	NULL
mice	NULL
and	NULL
cultured	NULL
overnight	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
DNA-binding	NULL
mixtures	NULL
containing	NULL
a	NULL
*°P-labeled	NULL
xB	NULL
probe	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

+	NULL
B	NULL
cell-depleted	NULL
T	NULL
lymphocytes	NULL
from	NULL
secondary	NULL
lymphoid	NULL
organs	NULL
.	NULL

Lymphokine-dependent	NULL
proliferation	NULL
of	NULL
IkBa	NULL
(	NULL
AN	NULL
)	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
was	NULL
again	NULL
observed	NULL
to	NULL
be	NULL
reduced	NULL
by	NULL
an	NULL
order	NULL
of	NULL
magnitude	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
by	NULL
anti-CD3	NULL
depends	NULL
on	NULL
IL-2	NULL
production	NULL
and	NULL
responsiveness	NULL
.	NULL

IxBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
exhibited	NULL
a	NULL
proliferative	NULL
defect	NULL
refractory	NULL
to	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
IL-2	NULL
after	NULL
activation	NULL
with	NULL
anti-CD3	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
although	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
deficit	NULL
was	NULL
less	NULL
dramatic	NULL
.	NULL

Costimulatory	NULL
signaling	NULL
by	NULL
CD28	NULL
has	NULL
been	NULL
described	NULL
as	NULL
critical	NULL
for	NULL
the	NULL
enhancement	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
observed	NULL
decrease	NULL
in	NULL
proliferation	NULL
was	NULL
due	NULL
to	NULL
inadequate	NULL
costimulation	NULL
in	NULL
these	NULL
cultures	NULL
and	NULL
if	NULL
signaling	NULL
through	NULL
the	NULL
CD28	NULL
receptor	NULL
could	NULL
reverse	NULL
the	NULL
impairment	NULL
of	NULL
cyto-kine-dependent	NULL
proliferation	NULL
,	NULL
we	NULL
added	NULL
an	NULL
activating	NULL
Ab	NULL
against	NULL
CD28	NULL
to	NULL
the	NULL
anti-CD3	NULL
stimulus	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
agonist	NULL
Abs	NULL
against	NULL
CD28	NULL
did	NULL
not	NULL
reverse	NULL
the	NULL
failure	NULL
of	NULL
cells	NULL
to	NULL
proliferate	NULL
normally	NULL
in	NULL
IL-2	NULL
or	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
under	NULL
biochemical	NULL
conditions	NULL
different	NULL
from	NULL
these	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
by	NULL
anti-CD3/28	NULL
or	NULL
by	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
)	NULL
is	NULL
potently	NULL
inhibited	NULL
by	NULL
the	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
transgene	NULL
(	NULL
21	NULL
,	NULL
31	NULL
)	NULL
,	NULL
but	NULL
had	NULL
not	NULL
assayed	NULL
PMA	NULL
alone	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
on	NULL
the	NULL
nuclear	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

during	NULL
PMA	NULL
treatment	NULL
,	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
NTg	NULL
and	NULL
Tg	NULL
mice	NULL
.	NULL

These	NULL
experiments	NULL
demonstrated	NULL
that	NULL
PMA	NULL
treatment	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
high	NULL
nuclear	NULL
levels	NULL
of	NULL
NF-KB	NULL
activity	NULL
in	NULL
cells	NULL
from	NULL
wild-type	NULL
animals	NULL
,	NULL
but	NULL
not	NULL
Tg	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
T	NULL
cell	NULL
competence	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
both	NULL
growth	NULL
signals	NULL
,	NULL
IL-2	NULL
and	NULL
IL-4	NULL
,	NULL
depends	NULL
on	NULL
normal	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
.	NULL

Selective	NULL
decreases	NULL
in	NULL
IL-4-induced	NULL
gene	NULL
expression	NULL
It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
growth	NULL
regulation	NULL
and	NULL
differentiation/	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
represent	NULL
mechanistically	NULL
distinct	NULL
effects	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
signaling	NULL
that	NULL
are	NULL
dependent	NULL
on	NULL
different	NULL
portions	NULL
of	NULL
the	NULL
cytokine	NULL
receptors	NULL
and	NULL
different	NULL
signaling	NULL
pathways	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

IL-4	NULL
does	NULL
not	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
the	NULL
finding	NULL
that	NULL
one	NULL
downstream	NULL
effect	NULL
of	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
,	NULL
proliferation	NULL
,	NULL
was	NULL
diminished	NULL
in	NULL
lymphoid	NULL
cells	NULL
whose	NULL
NF-	NULL
«	NULL
B/Rel	NULL
signaling	NULL
is	NULL
inhibited	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
IL-4	NULL
induction	NULL
of	NULL
target	NULL
gene	NULL
transcription	NULL
was	NULL
normal	NULL
.	NULL

Few	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
whose	NULL
expression	NULL
is	NULL
IL-4	NULL
dependent	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
IL-4	NULL
does	NULL
increase	NULL
IL-4Ra-chain	NULL
expression	NULL
(	NULL
8	NULL
)	NULL
and	NULL
transcription	NULL
of	NULL
the	NULL
mouse	NULL
IL-2RB-chain	NULL
gene	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analyses	NULL
to	NULL
analyze	NULL
the	NULL
effect	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
on	NULL
this	NULL
measure	NULL
of	NULL
IL-4	NULL
signaling	NULL
.	NULL

Levels	NULL
of	NULL
IL-4Ra	NULL
and	NULL
IL-2RB	NULL
mRNA	NULL
were	NULL
substantially	NULL
diminished	NULL
(	NULL
0.3	NULL
X	NULL
control	NULL
)	NULL
in	NULL
cells	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
after	NULL
IL-4	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
a	NULL
decrease	NULL
in	NULL
c-myc	NULL
mRNA	NULL
in	NULL
Tg	NULL
T	NULL
cells	NULL
after	NULL
activation	NULL
by	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
perhaps	NULL
reflecting	NULL
the	NULL
presence	NULL
of	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
c-myc	NULL
promoter	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Since	NULL
this	NULL
proto-oncogene	NULL
promoter	NULL
is	NULL
a	NULL
target	NULL
of	NULL
IL-4-mediated	NULL
signaling	NULL
that	NULL
may	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
IL-4-inducible	NULL
transcription	NULL
factor	NULL
Stat6	NULL
in	NULL
a	NULL
nonlymphoid	NULL
cell	NULL
line	NULL
(	NULL
36	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
levels	NULL
of	NULL
c-myc	NULL
mRNA	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
levels	NULL
of	NULL
c-mye	NULL
mRNA	NULL
expression	NULL
observed	NULL
before	NULL
and	NULL
after	NULL
IL-4	NULL
stimulation	NULL
of	NULL
Tg	NULL
T	NULL
cells	NULL
were	NULL
little	NULL
different	NULL
from	NULL
those	NULL
of	NULL
wild-type	NULL
controls	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
on	NULL
IL-4	NULL
signaling	NULL
pathways	NULL
include	NULL
decreased	NULL
expression	NULL
of	NULL
selected	NULL
target	NULL
genes	NULL
,	NULL
including	NULL
a	NULL
key	NULL
signaling	NULL
subunit	NULL
of	NULL
the	NULL
IL-4R	NULL
.	NULL

Activation	NULL
of	NULL
IL-4	NULL
signal	NULL
transduction	NULL
pathways	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
The	NULL
IL-4Ra	NULL
cytoplasmic	NULL
tail	NULL
lacks	NULL
intrinsic	NULL
tyrosine	NULL
or	NULL
serine/thre-onine	NULL
kinase	NULL
activity	NULL
,	NULL
but	NULL
upon	NULL
ligand	NULL
binding	NULL
,	NULL
resident	NULL
Janus	NULL
tyrosine	NULL
kinases	NULL
(	NULL
Jak	NULL
)	NULL
become	NULL
activated	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

These	NULL
kinases	NULL
are	NULL
thought	NULL
to	NULL
induce	NULL
phosphorylation	NULL
of	NULL
downstream	NULL
substrates	NULL
,	NULL
which	NULL
include	NULL
conserved	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
IL-4Ra	NULL
tail	NULL
,	NULL
IRS	NULL
proteins	NULL
IRS-1/2	NULL
,	NULL
and	NULL
the	NULL
IL-4-associated	NULL
Stat6	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

Recruitment	NULL
of	NULL
the	NULL
IRS	NULL
proteins	NULL
to	NULL
IL-4Ra	NULL
«	NULL
in	NULL
particular	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
an	NULL
essential	NULL
step	NULL
in	NULL
IL-4-induced	NULL
proliferation	NULL
of	NULL
certain	NULL
cell	NULL
lines	NULL
(	NULL
39-41	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
engagement	NULL
of	NULL
the	NULL
IL-4	NULL
(	NULL
but	NULL
not	NULL
IL-2	NULL
)	NULL
receptor	NULL
activates	NULL
a	NULL
signaling	NULL
pathway	NULL
in	NULL
which	NULL
recruitment	NULL
of	NULL
IRS-1	NULL
and	NULL
-2	NULL
to	NULL
a	NULL
distinct	NULL
tyrosine-phosphorylated	NULL
residue	NULL
in	NULL
IL4Ra	NULL
leads	NULL
to	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
IRS	NULL
proteins	NULL
in	NULL
cell	NULL
lines	NULL
,	NULL
followed	NULL
by	NULL
recruitment	NULL
of	NULL
downstream	NULL
signal	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
Thymus	NULL
T	NULL
cells	NULL
W.T	NULL
.	NULL

Tg	NULL
W.T	NULL
.	NULL

Tg	NULL
0	NULL
4	NULL
0	NULL
4	NULL
0	NULL
4	NULL
00	NULL
4	NULL
.	NULL

-a-	NULL
-	NULL
IL-4Ro	NULL
«	NULL
-	NULL
.	NULL

am	NULL
|	NULL
*-	NULL
IL-2RB	NULL
l	NULL
--	NULL
c-myc	NULL
CIC	NULL
-	NULL
Gor	NULL
g	NULL
--	NULL
sANa	NULL
B	NULL
c	NULL
4	NULL
e5	NULL
tso	NULL
5	NULL
?	NULL

500	NULL
O	NULL
Medium	NULL
as	NULL
aso	NULL
m	NULL
IL4	NULL
mg	NULL
o	NULL
~	NULL
W.T	NULL
.	NULL

_	NULL
Tg	NULL
FIGURE	NULL
2	NULL
.	NULL

Decreased	NULL
expression	NULL
of	NULL
IL-4	NULL
target	NULL
genes	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
RNAs	NULL
derived	NULL
from	NULL
cultured	NULL
lymphoid	NULL
cells	NULL
of	NULL
Tg	NULL
mice	NULL
and	NULL
littermate	NULL
controls	NULL
(	NULL
WT	NULL
)	NULL
.	NULL

Thymocytes	NULL
,	NULL
or	NULL
B	NULL
cell-depleted	NULL
T	NULL
cell	NULL
preparations	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
media	NULL
with	NULL
IL-4	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
,	NULL
or	NULL
without	NULL
exogenous	NULL
cytokine	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Samples	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
fractionated	NULL
under	NULL
denaturing	NULL
conditions	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
sequentially	NULL
hybridized	NULL
with	NULL
radiolabeled	NULL
IL-4R	NULL
«	NULL
,	NULL
IL-2R	NULL
$	NULL
,	NULL
and	NULL
c-myc	NULL
cDNA	NULL
probes	NULL
,	NULL
then	NULL
with	NULL
an	NULL
rRNA	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
Quantification	NULL
of	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
IL-4Ra	NULL
band	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
phosphor	NULL
imager	NULL
within	NULL
its	NULL
linear	NULL
range	NULL
.	NULL

Values	NULL
plotted	NULL
represent	NULL
arbitrary	NULL
units	NULL
of	NULL
signal	NULL
intensity	NULL
.	NULL

transducers	NULL
(	NULL
37	NULL
,	NULL
42	NULL
)	NULL
.	NULL

IRS	NULL
proteins	NULL
are	NULL
indispensible	NULL
for	NULL
IL-4-induced	NULL
mitogenesis	NULL
in	NULL
the	NULL
hemopoietic	NULL
cell	NULL
line	NULL
32D	NULL
,	NULL
and	NULL
thus	NULL
a	NULL
defect	NULL
in	NULL
IRS	NULL
activation	NULL
might	NULL
lead	NULL
to	NULL
decreased	NULL
IL-4-dependent	NULL
proliferation	NULL
of	NULL
lymphoid	NULL
cells	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
IRS	NULL
activation	NULL
is	NULL
altered	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
cells	NULL
compared	NULL
with	NULL
normal	NULL
primary	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
immunoprecipitations	NULL
of	NULL
IRS-1	NULL
or	NULL
IRS-2	NULL
,	NULL
followed	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

When	NULL
thymocytes	NULL
were	NULL
first	NULL
activated	NULL
,	NULL
rinsed	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
,	NULL
we	NULL
discovered	NULL
that	NULL
the	NULL
preactivation	NULL
step	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-2	NULL
independent	NULL
of	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-4	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
cells	NULL
was	NULL
normal	NULL
.	NULL

To	NULL
investigate	NULL
2221	NULL
further	NULL
whether	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
affected	NULL
the	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
influence	NULL
the	NULL
IRS-2	NULL
pathway	NULL
,	NULL
responses	NULL
to	NULL
IL-4	NULL
were	NULL
tested	NULL
in	NULL
cells	NULL
that	NULL
had	NULL
not	NULL
undergone	NULL
preactivation	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
con-ditions	NULL
,	NULL
the	NULL
primary	NULL
cells	NULL
demonstrated	NULL
IL-4-dependent	NULL
increases	NULL
in	NULL
IRS-2	NULL
phosphorylation	NULL
that	NULL
could	NULL
not	NULL
be	NULL
mimicked	NULL
by	NULL
IL-2	NULL
and	NULL
were	NULL
unaffected	NULL
by	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
.	NULL

Short-term	NULL
IL-4	NULL
treatment	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
in	NULL
resting	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
those	NULL
that	NULL
had	NULL
been	NULL
preactivated	NULL
(	NULL
C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
with	NULL
IRS-2	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
IL-4-induced	NULL
IRS-1	NULL
phosphorylation	NULL
was	NULL
moderately	NULL
reduced	NULL
in	NULL
Tg	NULL
cells	NULL
compared	NULL
with	NULL
wild-type	NULL
prep-arations	NULL
.	NULL

Inasmuch	NULL
as	NULL
control	NULL
immunoblots	NULL
revealed	NULL
similar	NULL
levels	NULL
of	NULL
IRS	NULL
proteins	NULL
in	NULL
wild-type	NULL
and	NULL
Tg	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
led	NULL
to	NULL
a	NULL
diminution	NULL
in	NULL
the	NULL
degree	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
,	NULL
but	NULL
not	NULL
IRS-2	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
.	NULL

Since	NULL
IRS-2	NULL
appears	NULL
be	NULL
the	NULL
predominant	NULL
IRS	NULL
protein	NULL
in	NULL
primary	NULL
T	NULL
lymphoid	NULL
cells	NULL
rather	NULL
than	NULL
IRS-1	NULL
(	NULL
43	NULL
)	NULL
,	NULL
the	NULL
degree	NULL
of	NULL
inhibition	NULL
selective	NULL
for	NULL
IRS-1	NULL
seemed	NULL
unlikely	NULL
to	NULL
explain	NULL
fully	NULL
the	NULL
more	NULL
substantial	NULL
impairment	NULL
of	NULL
proliferation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IRS	NULL
recruitment	NULL
and	NULL
activation	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
transcription	NULL
factor	NULL
family	NULL
are	NULL
induced	NULL
by	NULL
IL-4	NULL
treatment	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
37	NULL
,	NULL
38	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Following	NULL
IL-4-induced	NULL
phosphorylation	NULL
,	NULL
cytosolic	NULL
Staté	NULL
proteins	NULL
dimerize	NULL
,	NULL
translocate	NULL
to	NULL
the	NULL
nu-cleus	NULL
,	NULL
and	NULL
bind	NULL
to	NULL
consensus	NULL
sequences	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
IL-4-regulated	NULL
genes	NULL
.	NULL

Stat6	NULL
activation	NULL
represents	NULL
a	NULL
key	NULL
pathway	NULL
for	NULL
IL-4-induced	NULL
gene	NULL
induction	NULL
and	NULL
differentiation	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
45	NULL
)	NULL
,	NULL
but	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
Stat6	NULL
also	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
IL-4	NULL
(	NULL
46	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
on	NULL
this	NULL
IL-4	NULL
signaling	NULL
pathway	NULL
,	NULL
we	NULL
compared	NULL
Staté-binding	NULL
activity	NULL
in	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
NTg	NULL
and	NULL
Tg	NULL
mice	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
induction	NULL
of	NULL
nuclear	NULL
Stat6	NULL
was	NULL
2-fold	NULL
higher	NULL
in	NULL
wild-type	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
-expressing	NULL
cells	NULL
.	NULL

mRNA	NULL
levels	NULL
for	NULL
IL-4Ra	NULL
were	NULL
substantially	NULL
decreased	NULL
due	NULL
to	NULL
defective	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

signaling	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
and	NULL
this	NULL
inhibitory	NULL
effect	NULL
was	NULL
also	NULL
observed	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Stat6	NULL
activation	NULL
depends	NULL
on	NULL
the	NULL
availability	NULL
of	NULL
IL-4Ra-associated	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
32	NULL
,	NULL
44	NULL
)	NULL
,	NULL
so	NULL
we	NULL
infer	NULL
that	NULL
there	NULL
is	NULL
no	NULL
apparent	NULL
decrease	NULL
in	NULL
the	NULL
biochemical	NULL
efficiency	NULL
of	NULL
Stat6	NULL
activation	NULL
per	NULL
IL-4R	NULL
molecule	NULL
when	NULL
the	NULL
net	NULL
induction	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
nucleus	NULL
was	NULL
diminished	NULL
to	NULL
a	NULL
modest	NULL
extent	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
Stat6	NULL
by	NULL
IL-4	NULL
,	NULL
more	NULL
recent	NULL
work	NULL
has	NULL
established	NULL
that	NULL
IL-4	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
Stat5	NULL
isoforms	NULL
A	NULL
and	NULL
B	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
followed	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
Stat5-dependent	NULL
reporters	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
implicated	NULL
Stat5	NULL
as	NULL
A	NULL
ACTIVATED	NULL
B	NULL
RESTING	NULL
C	NULL
WT	NULL
_	NULL
Tg	NULL
wT	NULL
Tg	NULL
0	NULL
2	NULL
4	NULL
0	NULL
2	NULL
4	NULL
0	NULL
4	NULL
0	NULL
a	NULL
<	NULL
4	NULL
-	NULL
ins2	NULL
-	NULL
1	NULL
a-	NULL
~	NULL
ins	NULL
<	NULL
>	NULL
ins	NULL
ip	NULL
.	NULL

anti4RS2	NULL
*	NULL
|	NULL
ip	NULL
.	NULL

amins2	NULL
Lp	NULL
.	NULL

anti-IRS1	NULL
w.b	NULL
.	NULL

anti-PY	NULL
w.b	NULL
anti-PY	NULL
w.b	NULL
.	NULL

anti-PY	NULL
ip	NULL
.	NULL

ant-iRS2	NULL
M	NULL
ip	NULL
.	NULL

antHRS2	NULL
moves	NULL
sa	NULL
eel	NULL
_	NULL
ip	NULL
.	NULL

ant-IRS1	NULL
w.b	NULL
.	NULL

ant-RS2	NULL
w.b	NULL
antH-IRS2	NULL
w.b	NULL
.	NULL

1	NULL
FIGURE	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
transgene	NULL
on	NULL
cytokine-induced	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
phosphorylation	NULL
.	NULL

A	NULL
,	NULL
Activated	NULL
thymocytes	NULL
from	NULL
control	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
generated	NULL
by	NULL
overnight	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

These	NULL
preactivated	NULL
cells	NULL
were	NULL
rinsed	NULL
,	NULL
replated	NULL
in	NULL
complete	NULL
medium	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
IL-4	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

for	NULL
30	NULL
min	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
Thymocytes	NULL
from	NULL
wild	NULL
type	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
cultured	NULL
for	NULL
4	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IL-4	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
as	NULL
indicated	NULL
.	NULL

C	NULL
,	NULL
Activated	NULL
thymocytes	NULL
were	NULL
prepared	NULL
as	NULL
in	NULL
A	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
using	NULL
Abs	NULL
against	NULL
IRS-2	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
IRS-1	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
Abs	NULL
to	NULL
phosphotyrosine	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
subsequently	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
Abs	NULL
against	NULL
IRS-2	NULL
or	NULL
IRS-1	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
2222	NULL
NF-	NULL
«	NULL
B	NULL
AND	NULL
LYMPHOKINE-DEPENDENT	NULL
PROLIFERATION	NULL
OF	NULL
T	NULL
LYMPHOID	NULL
CELLS	NULL
«	NULL
Staté	NULL
WT	NULL
Tg	NULL
4s	NULL
40	NULL
0	NULL
4	NULL
0	NULL
4	NULL
4	NULL
4	NULL
State-	NULL
»	NULL
||	NULL
-	NULL
H	NULL
Stats	NULL
-	NULL
»	NULL
FIGURE	NULL
4	NULL
.	NULL

IL-4	NULL
induction	NULL
of	NULL
Staté-	NULL
and	NULL
Stat5-binding	NULL
activity	NULL
in	NULL
IxkBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
B	NULL
cell-depleted	NULL
lymphoid	NULL
cells	NULL
(	NULL
T	NULL
cells	NULL
)	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
of	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
activated	NULL
16	NULL
h	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
,	NULL
harvested	NULL
,	NULL
rinsed	NULL
,	NULL
and	NULL
recultured	NULL
30	NULL
min	NULL
in	NULL
complete	NULL
media	NULL
,	NULL
alone	NULL
or	NULL
supplemented	NULL
with	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Thymocytes	NULL
of	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
activated	NULL
16	NULL
h	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
harvested	NULL
,	NULL
rinsed	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml	NULL
for	NULL
30	NULL
min	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
Stat6é	NULL
by	NULL
mobility	NULL
shift	NULL
analyses	NULL
using	NULL
an	NULL
N4-spacer	NULL
(	NULL
Staté-specific	NULL
)	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
nucleotides	NULL
-122	NULL
to	NULL
-104	NULL
of	NULL
the	NULL
mouse	NULL
Ig	NULL
heavy	NULL
chain	NULL
germline	NULL
epsilon	NULL
promoter	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
indicated	NULL
complexes	NULL
was	NULL
confirmed	NULL
by	NULL
supershift	NULL
analyses	NULL
using	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Stat6	NULL
(	NULL
black	NULL
dot	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Impairment	NULL
of	NULL
Stat5	NULL
activation	NULL
by	NULL
IL-4	NULL
.	NULL

B	NULL
cell-depleted	NULL
lymphoid	NULL
cells	NULL
(	NULL
T	NULL
cells	NULL
)	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
of	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
activated	NULL
and	NULL
stimulated	NULL
with	NULL
IL-4	NULL
,	NULL
as	NULL
is	NULL
described	NULL
in	NULL
A	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
Stat5	NULL
by	NULL
mobility	NULL
shift	NULL
analyses	NULL
using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
that	NULL
contains	NULL
a	NULL
Stat5	NULL
consensus	NULL
sequence	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
indicated	NULL
complexes	NULL
was	NULL
confirmed	NULL
by	NULL
supershift	NULL
analyses	NULL
using	NULL
antiserum	NULL
specific	NULL
for	NULL
StatS5	NULL
(	NULL
A/B	NULL
)	NULL
(	NULL
black	NULL
dot	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
thymocytes	NULL
.	NULL

a	NULL
key	NULL
link	NULL
between	NULL
the	NULL
IL-4R	NULL
and	NULL
a	NULL
proliferative	NULL
response	NULL
to	NULL
this	NULL
cytokine	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
assayed	NULL
Stat5	NULL
induction	NULL
after	NULL
IL-4	NULL
treatment	NULL
of	NULL
activated	NULL
cells	NULL
from	NULL
wild-type	NULL
and	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
relatively	NULL
modest	NULL
effect	NULL
on	NULL
IRS	NULL
proteins	NULL
and	NULL
Stat6	NULL
,	NULL
Stat5	NULL
induction	NULL
was	NULL
greatly	NULL
diminished	NULL
in	NULL
cells	NULL
from	NULL
the	NULL
Tg	NULL
mice	NULL
as	NULL
compared	NULL
with	NULL
controls	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
interference	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
pathway	NULL
led	NULL
to	NULL
a	NULL
preferential	NULL
inhibition	NULL
of	NULL
Stat5	NULL
induction	NULL
as	NULL
compared	NULL
with	NULL
Stat6	NULL
.	NULL

IL-4R	NULL
expression	NULL
The	NULL
IL-4R	NULL
consists	NULL
of	NULL
an	NULL
IL-4Ra-chain	NULL
,	NULL
which	NULL
heterodimerizes	NULL
with	NULL
a	NULL
second	NULL
subunit	NULL
,	NULL
the	NULL
common	NULL
y-chain	NULL
(	NULL
y	NULL
,	NULL
)	NULL
,	NULL
which	NULL
is	NULL
shared	NULL
with	NULL
the	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
hemopoietin	NULL
receptor	NULL
superfamily	NULL
(	NULL
37	NULL
,	NULL
51-53	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
loss-of-function	NULL
mutants	NULL
and	NULL
Ab-blocking	NULL
studies	NULL
indicate	NULL
that	NULL
y	NULL
,	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
IL-4-induced	NULL
proliferation	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
Stat5	NULL
by	NULL
IL-4	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
due	NULL
to	NULL
interactions	NULL
with	NULL
Jak3	NULL
that	NULL
is	NULL
noncovalently	NULL
associated	NULL
with	NULL
y	NULL
,	NULL
rather	NULL
than	NULL
IL4Ra	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
how	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
leads	NULL
to	NULL
diminished	NULL
responses	NULL
to	NULL
IL-4	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
IL-4R	NULL
a	NULL
and	NULL
y	NULL
,	NULL
subunits	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
substantial	NULL
reduction	NULL
in	NULL
IL-4Ra	NULL
«	NULL
expression	NULL
on	NULL
Tg	NULL
thymocytes	NULL
and	NULL
T	NULL
cell	NULL
lymphocytes	NULL
compared	NULL
with	NULL
wild-type	NULL
counterparts	NULL
that	NULL
had	NULL
been	NULL
ren-	NULL
dered	NULL
competent	NULL
to	NULL
proliferate	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
y	NULL
,	NULL
subunit	NULL
was	NULL
normal	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
serve	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-4R	NULL
«	NULL
.	NULL

Mor-ever	NULL
,	NULL
decreased	NULL
IL-4-induced	NULL
proliferation	NULL
correlated	NULL
with	NULL
a	NULL
diminution	NULL
in	NULL
IL-4	NULL
signaling	NULL
reflected	NULL
most	NULL
by	NULL
Stat5	NULL
activation	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
by	NULL
IRS-1	NULL
phosphorylation	NULL
and	NULL
Stat6	NULL
induction	NULL
.	NULL

In	NULL
transfected	NULL
B	NULL
lymphoma	NULL
cells	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
some	NULL
signaling	NULL
pathways	NULL
by	NULL
IL-4	NULL
was	NULL
influenced	NULL
by	NULL
the	NULL
number	NULL
of	NULL
receptors	NULL
expressed	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
explored	NULL
whether	NULL
a	NULL
decreased	NULL
pool	NULL
of	NULL
available	NULL
IL-4Ra	NULL
cytoplasmic	NULL
tails	NULL
in	NULL
these	NULL
primary	NULL
cells	NULL
is	NULL
the	NULL
mechanistic	NULL
basis	NULL
for	NULL
the	NULL
observed	NULL
diminution	NULL
in	NULL
IL-4-induced	NULL
proliferation	NULL
.	NULL

To	NULL
do	NULL
so	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
increase	NULL
the	NULL
pool	NULL
of	NULL
IL-4Ra	NULL
tails	NULL
by	NULL
an	NULL
approach	NULL
independent	NULL
of	NULL
prior	NULL
activation	NULL
.	NULL

We	NULL
had	NULL
previously	NULL
characterized	NULL
Tg	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
T	NULL
lineage	NULL
specifically	NULL
expresses	NULL
a	NULL
chimera	NULL
of	NULL
mouse	NULL
IL-2R	NULL
$	NULL
and	NULL
the	NULL
IL-4Ra	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Both	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
these	NULL
mice	NULL
demonstrated	NULL
inducibility	NULL
of	NULL
Stat6	NULL
by	NULL
IL-2	NULL
and	NULL
other	NULL
evidence	NULL
that	NULL
these	NULL
cytoplasmic	NULL
tails	NULL
functioned	NULL
in	NULL
an	NULL
IL-4-specific	NULL
manner	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
crossed	NULL
chimeric	NULL
cytokine	NULL
receptor	NULL
Tg	NULL
mice	NULL
with	NULL
those	NULL
expressing	NULL
the	NULL
inhibitor	NULL
of	NULL
NF-KB	NULL
signaling	NULL
and	NULL
performed	NULL
proliferation	NULL
assays	NULL
measuring	NULL
the	NULL
response	NULL
to	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
these	NULL
cytokines	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Strikingly	NULL
,	NULL
under	NULL
no	NULL
condition	NULL
(	NULL
IL-4	NULL
alone	NULL
or	NULL
IL-2	NULL
with	NULL
IL-4	NULL
)	NULL
did	NULL
the	NULL
increased	NULL
pool	NULL
of	NULL
IL-4Ra	NULL
cytoplasmic	NULL
tails	NULL
in	NULL
double-Tg	NULL
mice	NULL
promote	NULL
an	NULL
enhancement	NULL
of	NULL
proliferation	NULL
above	NULL
that	NULL
obtained	NULL
with	NULL
IxBa	NULL
{	NULL
(	NULL
AN	NULL
)	NULL
sin-gle-Tg	NULL
animals	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
a	NULL
limiting	NULL
pool	NULL
of	NULL
cytoplasmic	NULL
tails	NULL
is	NULL
not	NULL
the	NULL
sole	NULL
basis	NULL
for	NULL
a	NULL
decreased	NULL
response	NULL
to	NULL
IL-4	NULL
.	NULL

Defective	NULL
StatSA	NULL
activation	NULL
in	NULL
IxBa	NULL
{	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
despite	NULL
IL-2R	NULL
expression	NULL
The	NULL
functional	NULL
IL-2R	NULL
in	NULL
mice	NULL
is	NULL
composed	NULL
of	NULL
three	NULL
subunits	NULL
:	NULL
IL-2Ra	NULL
,	NULL
IL-2R	NULL
$	NULL
,	NULL
and	NULL
the	NULL
y	NULL
,	NULL
,	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
finding	NULL
that	NULL
IL-4R	NULL
A.	NULL
Thymus	NULL
=	NULL
]	NULL
A	NULL
\	NULL
@	NULL
¥	NULL
M	NULL
Tg	NULL
IL4Ra	NULL
-	NULL
IL2RB	NULL
_	NULL
ye	NULL
chain	NULL
|	NULL
IL2R	NULL
«	NULL
B.	NULL
T	NULL
cells	NULL
W.T	NULL
.	NULL

f	NULL
ﬂ	NULL
N	NULL
IL4Re	NULL
.	NULL

-	NULL
IL2BB	NULL
-	NULL
ye	NULL
chain	NULL
FIGURE	NULL
5	NULL
.	NULL

Decreased	NULL
expression	NULL
of	NULL
IL-4Ra	NULL
and	NULL
normal	NULL
levels	NULL
of	NULL
IL-2R	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
.	NULL

Activated	NULL
thymocytes	NULL
(	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
)	NULL
from	NULL
Tg	NULL
mice	NULL
and	NULL
their	NULL
NTg	NULL
litter-mates	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
IL-2R	NULL
«	NULL
(	NULL
CD25	NULL
)	NULL
,	NULL
IL-2RB	NULL
(	NULL
CD122	NULL
)	NULL
,	NULL
y	NULL
,	NULL
,	NULL
IL-4Ra	NULL
,	NULL
CD3	NULL
,	NULL
and	NULL
TCRaB	NULL
,	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
indicated	NULL
surface	NULL
molecules	NULL
on	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
was	NULL
assessed	NULL
by	NULL
gating	NULL
on	NULL
TCRaRB®	NULL
thymocytes	NULL
(	NULL
4	NULL
)	NULL
or	NULL
on	NULL
CD3	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
and	NULL
then	NULL
displaying	NULL
the	NULL
indicated	NULL
histograms	NULL
.	NULL

Solid	NULL
lines	NULL
indicate	NULL
specific	NULL
staining	NULL
,	NULL
while	NULL
dashed	NULL
lines	NULL
(	NULL
--	NULL
)	NULL
show	NULL
the	NULL
relevant	NULL
control	NULL
histogram	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
anti-CD3/28-activated	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
is	NULL
essentially	NULL
normal	NULL
(	NULL
31	NULL
)	NULL
so	NULL
that	NULL
differences	NULL
in	NULL
receptor	NULL
internalization	NULL
are	NULL
unlikely	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
similarity	NULL
of	NULL
receptor	NULL
expression	NULL
on	NULL
wild-type	NULL
and	NULL
Tg	NULL
T	NULL
cells	NULL
.	NULL

Minor	NULL
variability	NULL
leading	NULL
to	NULL
the	NULL
apparent	NULL
presence	NULL
of	NULL
or	NULL
y	NULL
,	NULL
``	NULL
``	NULL
®	NULL
``	NULL
subpopulations	NULL
is	NULL
unlikely	NULL
to	NULL
account	NULL
for	NULL
differences	NULL
in	NULL
proliferation	NULL
in	NULL
light	NULL
of	NULL
the	NULL
high	NULL
frequency	NULL
of	NULL
T	NULL
cells	NULL
that	NULL
undergo	NULL
blast	NULL
transformation	NULL
under	NULL
identical	NULL
conditions	NULL
(	NULL
31	NULL
)	NULL
and	NULL
5-bromo-2'-deoxyuridine-labeling	NULL
indices	NULL
of	NULL
12-17	NULL
%	NULL
/h	NULL
for	NULL
wild-type	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
(	NULL
A.	NULL
L.	NULL
Mora	NULL
and	NULL
M.	NULL
Boothby	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6001	NULL
I	NULL
x	NULL
0	NULL
E	NULL
4004	NULL
s	NULL
o	NULL
WT	NULL
f	NULL
5	NULL
ChilL2/L4R	NULL
E	NULL
2007	NULL
®	NULL
IxBo	NULL
{	NULL
AN	NULL
)	NULL
®	NULL
®	NULL
ChilL2/L4R+IxBo	NULL
(	NULL
{	NULL
AN	NULL
)	NULL
anti-CD3	NULL
PMA	NULL
FIGURE	NULL
6	NULL
.	NULL

Failure	NULL
of	NULL
increased	NULL
IL-4Ra	NULL
cytoplasmic	NULL
tails	NULL
to	NULL
enhance	NULL
proliferation	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
cells	NULL
.	NULL

IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
were	NULL
crossed	NULL
with	NULL
a	NULL
Tg	NULL
mice	NULL
encoding	NULL
a	NULL
chimeric	NULL
IL-2/IL-4	NULL
receptor	NULL
to	NULL
the	NULL
T	NULL
lineage	NULL
(	NULL
chimeric	NULL
(	NULL
Chi	NULL
)	NULL
IL-2/4R	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

B	NULL
cell-depleted	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
from	NULL
pooled	NULL
lymph	NULL
nodes	NULL
and	NULL
spleens	NULL
from	NULL
wild-type	NULL
,	NULL
Chi	NULL
IL-2/4R	NULL
,	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
,	NULL
and	NULL
Chi	NULL
IL-2/4R	NULL
X	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
double-Tg	NULL
littermate	NULL
mice	NULL
.	NULL

Cell	NULL
preparations	NULL
were	NULL
stimulated	NULL
for	NULL
48	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
using	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
10	NULL
ug/m1	NULL
)	NULL
,	NULL
agonistic	NULL
Abs	NULL
against	NULL
CD28	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
each	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
pulsed	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
with	NULL
tritiated	NULL
thymidine	NULL
and	NULL
harvested	NULL
for	NULL
scintillation	NULL
counting	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
(	NULL
+*SEM	NULL
)	NULL
of	NULL
the	NULL
stimulation	NULL
indexes	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Stimulation	NULL
index	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
mean	NULL
cpm	NULL
stimulated	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
divided	NULL
by	NULL
the	NULL
arithmetic	NULL
mean	NULL
cpm	NULL
unstimulated	NULL
[	NULL
°HJthymidine	NULL
incorporation	NULL
.	NULL

expression	NULL
on	NULL
cells	NULL
from	NULL
I	NULL
«	NULL
xBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
was	NULL
substantially	NULL
decreased	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
IL-2R	NULL
subunits	NULL
.	NULL

The	NULL
signal-transducing	NULL
components	NULL
of	NULL
the	NULL
IL-2R	NULL
,	NULL
IL-2Rf3	NULL
,	NULL
and	NULL
y	NULL
,	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
in	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
Tg	NULL
and	NULL
wild-type	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
IL-2Ra	NULL
subunit	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
mouse	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
(	NULL
3-5	NULL
)	NULL
and	NULL
for	NULL
mouse	NULL
IL-2R	NULL
function	NULL
(	NULL
3	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
so	NULL
that	NULL
the	NULL
proliferative	NULL
defect	NULL
of	NULL
thymocytes	NULL
could	NULL
arise	NULL
from	NULL
a	NULL
decrease	NULL
in	NULL
IL-2R	NULL
«	NULL
expression	NULL
.	NULL

Despite	NULL
reports	NULL
that	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
proteins	NULL
are	NULL
potent	NULL
frans-activators	NULL
of	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
in	NULL
transfected	NULL
cells	NULL
,	NULL
IL-2Ra/CD25	NULL
expression	NULL
on	NULL
IkxBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
was	NULL
at	NULL
most	NULL
slightly	NULL
lower	NULL
than	NULL
on	NULL
wild-type	NULL
cells	NULL
,	NULL
and	NULL
we	NULL
observed	NULL
only	NULL
a	NULL
modest	NULL
decrease	NULL
in	NULL
IL-2Ra	NULL
expression	NULL
on	NULL
mature	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Since	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
subunits	NULL
on	NULL
T	NULL
lymphoid	NULL
cells	NULL
appeared	NULL
normal	NULL
,	NULL
the	NULL
data	NULL
indicate	NULL
that	NULL
decreased	NULL
proliferation	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
reflects	NULL
a	NULL
failure	NULL
to	NULL
capacitate	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
receptor	NULL
subunits	NULL
.	NULL

Although	NULL
a	NULL
subject	NULL
on	NULL
which	NULL
there	NULL
is	NULL
disagreement	NULL
,	NULL
the	NULL
nuclear	NULL
induction	NULL
of	NULL
Stat5	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
key	NULL
event	NULL
in	NULL
IL-2-induced	NULL
proliferation	NULL
(	NULL
49	NULL
,	NULL
54-56	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
our	NULL
data	NULL
on	NULL
IL-4-induced	NULL
Stat5	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
inhibition	NULL
of	NULL
Stats	NULL
induction	NULL
might	NULL
represent	NULL
a	NULL
defect	NULL
shared	NULL
by	NULL
IL-2R	NULL
and	NULL
IL-4R	NULL
signaling	NULL
when	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
inhibited	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
measured	NULL
activation	NULL
of	NULL
Stat5	NULL
by	NULL
IL-2	NULL
.	NULL

Like	NULL
IL-4	NULL
,	NULL
IL-2	NULL
induces	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
expressed	NULL
from	NULL
related	NULL
genes	NULL
(	NULL
Stat5SA	NULL
and	NULL
Stat5B	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
influence	NULL
of	NULL
IxBa	NULL
&	NULL
(	NULL
AN	NULL
)	NULL
on	NULL
IL-2-induced	NULL
proliferation	NULL
could	NULL
be	NULL
correlated	NULL
with	NULL
phosphorylation	NULL
of	NULL
Stat5	NULL
,	NULL
we	NULL
activated	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
Tg	NULL
and	NULL
wild-type	NULL
mice	NULL
,	NULL
followed	NULL
by	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
extracts	NULL
of	NULL
control	NULL
and	NULL
IL-2-treated	NULL
cells	NULL
.	NULL

This	NULL
activation	NULL
step	NULL
was	NULL
designed	NULL
to	NULL
mimic	NULL
the	NULL
conditions	NULL
of	NULL
proliferation	NULL
assays	NULL
and	NULL
promote	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
«	NULL
.	NULL

It	NULL
also	NULL
leads	NULL
to	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
wild-type	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
IL-2	NULL
production	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
Tg	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
in	NULL
thymocytes	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
that	NULL
comigrate	NULL
with	NULL
Stat5	NULL
was	NULL
reduced	NULL
in	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
.	NULL

Endogenous	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
wild-type	NULL
but	NULL
not	NULL
Tg	NULL
cells	NULL
led	NULL
to	NULL
high	NULL
basal	NULL
levels	NULL
of	NULL
2223	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
extracts	NULL
from	NULL
wild-type	NULL
thymocytes	NULL
,	NULL
but	NULL
not	NULL
those	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
Tg	NULL
mice	NULL
,	NULL
and	NULL
even	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
substantial	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
Stat5	NULL
in	NULL
this	NULL
complex	NULL
was	NULL
validated	NULL
using	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
both	NULL
StatSA	NULL
and	NULL
B	NULL
,	NULL
which	NULL
eliminated	NULL
the	NULL
Stat5	NULL
complex	NULL
and	NULL
created	NULL
a	NULL
supershifted	NULL
band	NULL
of	NULL
slower	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

An	NULL
independent	NULL
Ab	NULL
specific	NULL
for	NULL
StatSA	NULL
also	NULL
supershifted	NULL
the	NULL
indicated	NULL
complex	NULL
,	NULL
whereas	NULL
a	NULL
control	NULL
serum	NULL
did	NULL
not	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Stat5	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
also	NULL
was	NULL
impaired	NULL
(	NULL
B	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
better	NULL
which	NULL
form	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Stat5	NULL
contributed	NULL
to	NULL
the	NULL
mobility	NULL
shift	NULL
activity	NULL
,	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
antiserum	NULL
against	NULL
the	NULL
individual	NULL
isoforms	NULL
of	NULL
Stat5	NULL
,	NULL
Stat5A	NULL
,	NULL
and	NULL
Stat5B	NULL
,	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
antiphosphotyrosine	NULL
Ab	NULL
.	NULL

As	NULL
in	NULL
A	NULL
,	NULL
endogenous	NULL
IL-2	NULL
production	NULL
by	NULL
wild-type	NULL
thymocytes	NULL
led	NULL
to	NULL
a	NULL
substantial	NULL
level	NULL
of	NULL
Stat5A	NULL
tyrosine	NULL
phosphorylation	NULL
that	NULL
was	NULL
not	NULL
further	NULL
increased	NULL
by	NULL
exogenous	NULL
IL-2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
observed	NULL
far	NULL
less	NULL
phosphorylation	NULL
of	NULL
StatSA	NULL
in	NULL
cells	NULL
from	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
as	NULL
compared	NULL
with	NULL
controls	NULL
,	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
did	NULL
not	NULL
induce	NULL
phosphoStat5A	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Although	NULL
at	NULL
lower	NULL
signal	NULL
intensity	NULL
overall	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Stat5B	NULL
phosphorylation	NULL
in	NULL
IL-2-treated	NULL
cells	NULL
from	NULL
Tg	NULL
animals	NULL
was	NULL
indistinguishable	NULL
from	NULL
wild-type	NULL
samples	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggested	NULL
that	NULL
IL-2	NULL
induction	NULL
of	NULL
Stat5B	NULL
homodimers	NULL
and	NULL
perhaps	NULL
Stat5AB	NULL
heterodimers	NULL
was	NULL
quantitatively	NULL
less	NULL
affected	NULL
than	NULL
that	NULL
of	NULL
Stat5A	NULL
homodimers	NULL
.	NULL

While	NULL
the	NULL
decreased	NULL
StatSA	NULL
phosphorylation	NULL
might	NULL
have	NULL
been	NULL
attributed	NULL
to	NULL
a	NULL
requirement	NULL
for	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

signaling	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
StatSA	NULL
protein	NULL
levels	NULL
,	NULL
wild-type	NULL
and	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
expressed	NULL
similar	NULL
levels	NULL
of	NULL
total	NULL
Stat5A	NULL
and	NULL
Stat5B	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
in	NULL
Tg	NULL
T	NULL
lineage	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
impaired	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
Stat5A	NULL
despite	NULL
expression	NULL
of	NULL
all	NULL
subunits	NULL
of	NULL
the	NULL
IL-2R	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
observations	NULL
linking	NULL
Stat5	NULL
to	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
49	NULL
,	NULL
54-56	NULL
)	NULL
through	NULL
association	NULL
with	NULL
IL-2	NULL
but	NULL
not	NULL
Ag	NULL
receptors	NULL
(	NULL
49	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
observed	NULL
impairment	NULL
in	NULL
IL-2-inducible	NULL
proliferation	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
defective	NULL
Stat5A	NULL
activation	NULL
.	NULL

The	NULL
evidence	NULL
that	NULL
the	NULL
IxB/NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
system	NULL
can	NULL
regulate	NULL
receptor	NULL
capacitation	NULL
raises	NULL
the	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
such	NULL
a	NULL
role	NULL
is	NULL
limited	NULL
to	NULL
cytokines	NULL
whose	NULL
receptor	NULL
uses	NULL
Jak1	NULL
and	NULL
Jak3	NULL
to	NULL
induce	NULL
Stat5	NULL
,	NULL
or	NULL
instead	NULL
may	NULL
be	NULL
more	NULL
general	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
ability	NULL
of	NULL
IL-12	NULL
to	NULL
enhance	NULL
the	NULL
proliferation	NULL
of	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

PMA-primed	NULL
thymocytes	NULL
could	NULL
not	NULL
be	NULL
costimulated	NULL
by	NULL
IL-12	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
IL-12-en-hanced	NULL
proliferation	NULL
of	NULL
PMA-primed	NULL
T	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
IkBa	NULL
(	NULL
AN	NULL
)	NULL
,	NULL
although	NULL
there	NULL
was	NULL
no	NULL
enhancement	NULL
of	NULL
the	NULL
response	NULL
to	NULL
other	NULL
proliferative	NULL
stimuli	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
effect	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
the	NULL
action	NULL
of	NULL
this	NULL
cytokine	NULL
through	NULL
different	NULL
Janus	NULL
kinases	NULL
(	NULL
Jak2	NULL
and	NULL
Tyk2	NULL
)	NULL
and	NULL
Stat	NULL
proteins	NULL
(	NULL
Stat3	NULL
and	NULL
Statd4	NULL
)	NULL
suggests	NULL
the	NULL
potential	NULL
for	NULL
additional	NULL
NF-	NULL
«	NULL
B-dependent	NULL
mechanisms	NULL
of	NULL
receptor	NULL
capacitation	NULL
.	NULL

Discussion	NULL
The	NULL
activation	NULL
of	NULL
lymphocytes	NULL
after	NULL
engagement	NULL
of	NULL
their	NULL
Ag-spe-cific	NULL
receptor	NULL
is	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
immune	NULL
responses	NULL
.	NULL

Lymphocyte	NULL
activation	NULL
leads	NULL
to	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Importantly	NULL
,	NULL
this	NULL
activation	NULL
step	NULL
also	NULL
induces	NULL
the	NULL
competence	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
proliferative	NULL
signals	NULL
provided	NULL
by	NULL
these	NULL
lymphokines	NULL
(	NULL
5	NULL
,	NULL
12-16	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
set	NULL
of	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
this	NULL
enhancement	NULL
of	NULL
cytokine	NULL
responsiveness	NULL
of	NULL
normal	NULL
lymphoid	NULL
cells	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

Signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
after	NULL
engagement	NULL
of	NULL
the	NULL
TCR	NULL
include	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factor	NULL
family	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
but	NULL
neither	NULL
IL-2	NULL
nor	NULL
IL-4	NULL
induces	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factors	NULL
.	NULL

In	NULL
the	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
2224	NULL
A	NULL
.	NULL

C	NULL
Stat5A/B	NULL
WT	NULL
Tg	NULL
at	NULL
®	NULL
0	NULL
20	NULL
0	NULL
2	NULL
2	NULL
2	NULL
®	NULL
F	NULL
225	NULL
120	NULL
-	NULL
x	NULL
84	NULL
Stats	NULL
-	NULL
56	NULL
225	NULL
ts	NULL
==	NULL
be	NULL
as	NULL
is	NULL
120	NULL
~*	NULL
84	NULL
56	NULL
B	NULL
WT	NULL
Tg	NULL
0	NULL
2	NULL
0	NULL
2	NULL
sts	NULL
-|	NULL
UOW	NULL
NF-	NULL
«	NULL
B	NULL
AND	NULL
LYMPHOKINE-DEPENDENT	NULL
PROLIFERATION	NULL
OF	NULL
T	NULL
LYMPHOID	NULL
CELLS	NULL
StatSA	NULL
Stat5B	NULL
WT	NULL
_	NULL
tg	NULL
WT	NULL
_	NULL
Tg	NULL
0	NULL
20	NULL
0	NULL
20	NULL
0	NULL
2	NULL
0	NULL
2	NULL
bow	NULL
be	NULL
camnd	NULL
ind	NULL
«	NULL
'le	NULL
w.b	NULL
.	NULL

anti-PY	NULL
like	NULL
:	NULL
we	NULL
-	NULL
-~le	NULL
wep	NULL
ime	NULL
b	NULL
one	NULL
los	NULL
toa	NULL
ak	NULL
91	NULL
w.b	NULL
.	NULL

anti-Stat5	NULL
(	NULL
A	NULL
or	NULL
B	NULL
)	NULL
anti-Stat5A	NULL
anti-StatS5B	NULL
FIGURE	NULL
7	NULL
.	NULL

Defective	NULL
induction	NULL
of	NULL
StatSA	NULL
in	NULL
activated	NULL
,	NULL
IL-2-treated	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Thymocytes	NULL
from	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
activated	NULL
overnight	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
and	NULL
anti-CD28	NULL
,	NULL
harvested	NULL
,	NULL
rinsed	NULL
,	NULL
and	NULL
recultured	NULL
30	NULL
min	NULL
with	NULL
media	NULL
,	NULL
alone	NULL
or	NULL
supplemented	NULL
with	NULL
IL-2	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

B	NULL
,	NULL
B	NULL
cell-depleted	NULL
lymphoid	NULL
cells	NULL
(	NULL
T	NULL
cells	NULL
)	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
of	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
were	NULL
activated	NULL
16	NULL
h	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
,	NULL
harvested	NULL
,	NULL
rinsed	NULL
,	NULL
and	NULL
recultured	NULL
30	NULL
min	NULL
in	NULL
complete	NULL
media	NULL
,	NULL
alone	NULL
or	NULL
supplemented	NULL
with	NULL
IL-2	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
from	NULL
these	NULL
treated	NULL
cells	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
Stat5	NULL
by	NULL
mobility	NULL
shift	NULL
analyses	NULL
using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
that	NULL
contains	NULL
a	NULL
Stat5	NULL
consensus	NULL
sequence	NULL
.	NULL

The	NULL
background	NULL
of	NULL
Stat5-binding	NULL
activity	NULL
in	NULL
cells	NULL
not	NULL
treated	NULL
with	NULL
IL-2	NULL
is	NULL
due	NULL
to	NULL
IL-2	NULL
release	NULL
from	NULL
the	NULL
activated	NULL
cells	NULL
;	NULL
this	NULL
band	NULL
was	NULL
not	NULL
present	NULL
when	NULL
using	NULL
extracts	NULL
of	NULL
resting	NULL
cells	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
indicated	NULL
complexes	NULL
was	NULL
confirmed	NULL
in	NULL
thymocyte	NULL
preparations	NULL
by	NULL
supershift	NULL
analyses	NULL
using	NULL
antiserum	NULL
specific	NULL
for	NULL
Stat5	NULL
(	NULL
4/8	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Activated	NULL
thymocytes	NULL
(	NULL
16-h	NULL
culture	NULL
in	NULL
PMA	NULL
and	NULL
ionomycin	NULL
)	NULL
were	NULL
recultured	NULL
30	NULL
min	NULL
in	NULL
complete	NULL
media	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mouse	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m1	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
from	NULL
these	NULL
stimulated	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
using	NULL
an	NULL
anti-Stat5A	NULL
or	NULL
Stat5B	NULL
antiserum	NULL
.	NULL

Immune	NULL
precipitates	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
using	NULL
an	NULL
anti-phosphotyrosine	NULL
Ab	NULL
(	NULL
RC-20	NULL
)	NULL
.	NULL

Following	NULL
this	NULL
procedure	NULL
,	NULL
these	NULL
filters	NULL
were	NULL
then	NULL
divided	NULL
,	NULL
stripped	NULL
,	NULL
separately	NULL
reprobed	NULL
using	NULL
the	NULL
anti-Stat5A	NULL
or	NULL
Stat5B	NULL
antiserum	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
repositioned	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
StatSA	NULL
and	NULL
StatSB	NULL
band	NULL
is	NULL
marked	NULL
with	NULL
an	NULL
asterisk	NULL
and	NULL
a	NULL
diamond	NULL
,	NULL
respectively	NULL
.	NULL

present	NULL
study	NULL
,	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
inhibition	NULL
of	NULL
IxBa	NULL
degradation	NULL
through	NULL
expression	NULL
of	NULL
a	NULL
franms-dominant	NULL
inhibitor	NULL
(	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
impair	NULL
the	NULL
competence	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
proliferative	NULL
stimulus	NULL
of	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
IL-2	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
each	NULL
cytokine	NULL
to	NULL
induce	NULL
Stat5	NULL
was	NULL
diminished	NULL
.	NULL

This	NULL
finding	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
may	NULL
play	NULL
a	NULL
general	NULL
role	NULL
in	NULL
the	NULL
cytokine	NULL
responsiveness	NULL
of	NULL
lymphoid	NULL
cells	NULL
by	NULL
a	NULL
Stat5-dependent	NULL
mechanism	NULL
.	NULL

Two	NULL
general	NULL
mechanisms	NULL
for	NULL
enhancing	NULL
the	NULL
competence	NULL
of	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
lymphokines	NULL
can	NULL
be	NULL
envisaged	NULL
.	NULL

In	NULL
the	NULL
first	NULL
,	NULL
the	NULL
composition	NULL
and	NULL
number	NULL
of	NULL
receptors	NULL
are	NULL
regulated	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
.	NULL

Examples	NULL
of	NULL
this	NULL
mechanism	NULL
include	NULL
induction	NULL
of	NULL
the	NULL
IL-2Ra-chain	NULL
,	NULL
whose	NULL
association	NULL
with	NULL
IL-2RB	NULL
and	NULL
y	NULL
,	NULL
dramatically	NULL
influences	NULL
ligand	NULL
affinity	NULL
,	NULL
and	NULL
regulated	NULL
changes	NULL
in	NULL
the	NULL
number	NULL
of	NULL
IL-2RB-chains	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Capacitation	NULL
,	NULL
in	NULL
which	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
receptors	NULL
are	NULL
potentiated	NULL
after	NULL
cellular	NULL
activation	NULL
or	NULL
differentiation	NULL
(	NULL
5	NULL
,	NULL
15-18	NULL
,	NULL
57	NULL
)	NULL
,	NULL
provides	NULL
an	NULL
alternative	NULL
mechanism	NULL
of	NULL
regulation	NULL
.	NULL

Receptor	NULL
capacitation	NULL
offers	NULL
a	NULL
powerful	NULL
means	NULL
for	NULL
integration	NULL
of	NULL
disparate	NULL
stimuli	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
in	NULL
some	NULL
systems	NULL
,	NULL
IL-4	NULL
may	NULL
not	NULL
provide	NULL
a	NULL
sufficient	NULL
signal	NULL
for	NULL
lymphocyte	NULL
proliferation	NULL
unless	NULL
costimulatory	NULL
or	NULL
Ag	NULL
receptors	NULL
have	NULL
also	NULL
bound	NULL
to	NULL
a	NULL
ligand	NULL
,	NULL
while	NULL
in	NULL
others	NULL
the	NULL
response	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
TCR	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
IL-12	NULL
signaling	NULL
may	NULL
lead	NULL
to	NULL
inhibition	NULL
of	NULL
Stat6	NULL
activation	NULL
by	NULL
IL-4R	NULL
(	NULL
15-18	NULL
,	NULL
58	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
work	NULL
support	NULL
a	NULL
role	NULL
for	NULL
NF-	NULL
«	NULL
B/Rel	NULL
signaling	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
lymphoid	NULL
proliferation	NULL
and	NULL
Stat5	NULL
induction	NULL
by	NULL
IL-4	NULL
.	NULL

Such	NULL
mechanisms	NULL
may	NULL
also	NULL
apply	NULL
to	NULL
the	NULL
regula-	NULL
tion	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

IL-4	NULL
protects	NULL
lymphoid	NULL
cells	NULL
against	NULL
apoptosis	NULL
in	NULL
several	NULL
contexts	NULL
:	NULL
programmed	NULL
cell	NULL
death	NULL
of	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
59-61	NULL
)	NULL
,	NULL
and	NULL
Fas-induced	NULL
apoptosis	NULL
of	NULL
activated	NULL
B	NULL
cells	NULL
(	NULL
62	NULL
)	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
while	NULL
the	NULL
addition	NULL
of	NULL
IL-4	NULL
to	NULL
cultures	NULL
decreased	NULL
the	NULL
apoptotic	NULL
susceptibility	NULL
of	NULL
anti-CD3-treated	NULL
wild-type	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
cytokine	NULL
did	NULL
not	NULL
protect	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
TCR	NULL
cross-linking	NULL
(	NULL
A.	NULL
Mora	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
IL-4-induced	NULL
Stat6	NULL
was	NULL
entirely	NULL
dispensable	NULL
for	NULL
the	NULL
IL-4-mediated	NULL
protection	NULL
against	NULL
apoptosis	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Since	NULL
Stat5	NULL
activity	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
mediating	NULL
IL-2-induced	NULL
survival	NULL
signals	NULL
(	NULL
63	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
IL-4-induced	NULL
Stat5	NULL
is	NULL
one	NULL
mechanism	NULL
by	NULL
which	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
AN	NULL
)	NULL
blocks	NULL
survival	NULL
signaling	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
subunits	NULL
after	NULL
activation	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
lymphoid	NULL
cells	NULL
,	NULL
hyporesponsiveness	NULL
to	NULL
IL-4	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
IL-4R	NULL
expression	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
basal	NULL
IL-4Ra	NULL
mRNA	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
may	NULL
reflect	NULL
an	NULL
important	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
promoter	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Stat6	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
IL-4-dependent	NULL
promoters	NULL
can	NULL
require	NULL
cooperation	NULL
with	NULL
adjacent	NULL
cis-acting	NULL
elements	NULL
(	NULL
64	NULL
,	NULL
65	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
can	NULL
cooperate	NULL
with	NULL
Stat6	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-4-dependent	NULL
germline	NULL
epsilon	NULL
promoter	NULL
from	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
locus	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
relatively	NULL
modest	NULL
decrease	NULL
in	NULL
IL-4-induced	NULL
Stat6-binding	NULL
activity	NULL
may	NULL
be	NULL
amplified	NULL
functionally	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
-expressing	NULL
T	NULL
lymphoid	NULL
cells	NULL
because	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
the	NULL
inducible	NULL
frans-activators	NULL
c-Rel	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
150	NULL
100	NULL
50	NULL
[	NULL
3H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
(	NULL
x103	NULL
cpm	NULL
)	NULL
CD3	NULL
CD3	NULL
PMA	NULL
+	NULL
CD28	NULL
FIGURE	NULL
8	NULL
.	NULL

Decreased	NULL
proliferation	NULL
of	NULL
PMA-treated	NULL
cells	NULL
costimulated	NULL
with	NULL
IL-12	NULL
.	NULL

B	NULL
cell-depleted	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
from	NULL
pooled	NULL
lymph	NULL
nodes	NULL
and	NULL
spleens	NULL
from	NULL
wild-type	NULL
and	NULL
Tg	NULL
mice	NULL
.	NULL

Cell	NULL
preparations	NULL
were	NULL
stimulated	NULL
for	NULL
48	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
using	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
agonistic	NULL
Abs	NULL
against	NULL
CD28	NULL
(	NULL
10	NULL
pg/m1	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
each	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
pulsed	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
with	NULL
tritiated	NULL
thymidine	NULL
and	NULL
harvested	NULL
for	NULL
scintillation	NULL
counting	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
(	NULL
~SEM	NULL
)	NULL
tritiated	NULL
thymidine	NULL
incorporation	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

and	NULL
RelA	NULL
is	NULL
inhibited	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

This	NULL
decrease	NULL
in	NULL
receptor	NULL
number	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
diminished	NULL
capacity	NULL
to	NULL
activate	NULL
downstream	NULL
signaling	NULL
pathways	NULL
,	NULL
particularly	NULL
that	NULL
leading	NULL
to	NULL
Stat5	NULL
induction	NULL
.	NULL

However	NULL
,	NULL
we	NULL
consider	NULL
it	NULL
unlikely	NULL
that	NULL
the	NULL
decreased	NULL
expression	NULL
of	NULL
IL-4Ra	NULL
fully	NULL
accounts	NULL
for	NULL
the	NULL
impaired	NULL
IL-4-dependent	NULL
proliferation	NULL
of	NULL
IkBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
lymphoid	NULL
cells	NULL
since	NULL
a	NULL
constitutively	NULL
expressed	NULL
Tg	NULL
receptor	NULL
competent	NULL
to	NULL
generate	NULL
IL-4-specific	NULL
signals	NULL
(	NULL
26	NULL
)	NULL
was	NULL
unable	NULL
to	NULL
ameliorate	NULL
the	NULL
proliferative	NULL
defect	NULL
stemming	NULL
from	NULL
inhibition	NULL
of	NULL
NF-KB	NULL
.	NULL

While	NULL
NF-	NULL
«	NULL
B/Rel	NULL
!	NULL

proteins	NULL
clearly	NULL
participate	NULL
in	NULL
an	NULL
important	NULL
signal	NULL
transduction	NULL
pathway	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
most	NULL
studies	NULL
on	NULL
their	NULL
potential	NULL
role	NULL
in	NULL
cytokine	NULL
signaling	NULL
have	NULL
focused	NULL
on	NULL
culture-adapted	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
these	NULL
settings	NULL
,	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
66	NULL
,	NULL
67	NULL
)	NULL
.	NULL

How	NULL
these	NULL
findings	NULL
with	NULL
cell	NULL
lines	NULL
apply	NULL
to	NULL
normal	NULL
T	NULL
cells	NULL
is	NULL
unclear	NULL
,	NULL
since	NULL
complete	NULL
inactivation	NULL
of	NULL
either	NULL
c-Rel	NULL
or	NULL
RelA	NULL
by	NULL
gene	NULL
targeting	NULL
had	NULL
no	NULL
apparent	NULL
effect	NULL
on	NULL
IL-2Ra	NULL
(	NULL
CD25	NULL
)	NULL
gene	NULL
expression	NULL
(	NULL
23	NULL
,	NULL
68	NULL
)	NULL
.	NULL

These	NULL
gene	NULL
inactivation	NULL
studies	NULL
could	NULL
be	NULL
explained	NULL
on	NULL
the	NULL
basis	NULL
that	NULL
either	NULL
frams-activating	NULL
subunit	NULL
is	NULL
sufficient	NULL
to	NULL
achieve	NULL
normal	NULL
transcriptional	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
interferes	NULL
with	NULL
the	NULL
nuclear	NULL
induction	NULL
of	NULL
both	NULL
c-Rel	NULL
and	NULL
RelA	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
yet	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
thymocytes	NULL
can	NULL
express	NULL
normal	NULL
levels	NULL
of	NULL
IL-2Ra	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
,	NULL
.	NULL

Despite	NULL
normal	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
subunits	NULL
,	NULL
direct	NULL
evidence	NULL
of	NULL
a	NULL
capacitation	NULL
mechanism	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
overall	NULL
Stat5	NULL
activation	NULL
was	NULL
dramatically	NULL
decreased	NULL
,	NULL
with	NULL
a	NULL
particularly	NULL
substantial	NULL
effect	NULL
on	NULL
Stat5A	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5B	NULL
in	NULL
I	NULL
«	NULL
xBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
further	NULL
suggests	NULL
that	NULL
these	NULL
cells	NULL
express	NULL
functional	NULL
IL-2R	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
this	NULL
capacitation	NULL
mechanism	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
both	NULL
Jak1	NULL
and	NULL
Jak3	NULL
are	NULL
essential	NULL
for	NULL
activation	NULL
of	NULL
Stat5	NULL
,	NULL
whereas	NULL
only	NULL
Jak1	NULL
appears	NULL
essential	NULL
for	NULL
Stat6	NULL
induction	NULL
(	NULL
69-74	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Jak3	NULL
deficiency	NULL
leads	NULL
to	NULL
a	NULL
homeo-static	NULL
defect	NULL
characterized	NULL
by	NULL
a	NULL
preferential	NULL
decrease	NULL
in	NULL
the	NULL
CD8	NULL
*	NULL
lineage	NULL
relative	NULL
to	NULL
CD4	NULL
*	NULL
cells	NULL
(	NULL
75-77	NULL
)	NULL
,	NULL
which	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
phenotype	NULL
in	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
mice	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
attractive	NULL
hypothesis	NULL
is	NULL
that	NULL
Jak3	NULL
is	NULL
inhibited	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
expression	NULL
in	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

Although	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
the	NULL
inhibition	NULL
of	NULL
Stat5A	NULL
induction	NULL
accounts	NULL
for	NULL
the	NULL
entire	NULL
proliferative	NULL
defect	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
observed	NULL
2225	NULL
decreases	NULL
in	NULL
Stat5	NULL
expression	NULL
suggests	NULL
a	NULL
parallel	NULL
to	NULL
studies	NULL
of	NULL
IL-2-dependent	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
Stat5A-deficient	NULL
mice	NULL
(	NULL
54-56	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Anti-CD3-stimulated	NULL
splenocytes	NULL
from	NULL
Stat5A-deficient	NULL
mice	NULL
exhibited	NULL
normal	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
and	NULL
decreased	NULL
proliferation	NULL
not	NULL
unlike	NULL
that	NULL
observed	NULL
in	NULL
cultures	NULL
of	NULL
IxBa	NULL
(	NULL
AN	NULL
)	NULL
T	NULL
cells	NULL
supplemented	NULL
with	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
failure	NULL
to	NULL
sustain	NULL
increased	NULL
CD25	NULL
expression	NULL
was	NULL
observed	NULL
only	NULL
when	NULL
cells	NULL
were	NULL
rinsed	NULL
and	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
in	NULL
IL-2	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
TCR	NULL
stimulus	NULL
(	NULL
78	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
present	NULL
observations	NULL
using	NULL
T	NULL
cells	NULL
subjected	NULL
to	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

signaling	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
phenotype	NULL
of	NULL
Stat5A-null	NULL
T	NULL
cells	NULL
when	NULL
compared	NULL
under	NULL
similar	NULL
condition	NULL
and	NULL
with	NULL
other	NULL
studies	NULL
suggesting	NULL
differential	NULL
roles	NULL
for	NULL
these	NULL
proteins	NULL
(	NULL
79	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
present	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
conclusion	NULL
of	NULL
previous	NULL
studies	NULL
that	NULL
Stat5	NULL
is	NULL
critical	NULL
for	NULL
IL-2-	NULL
as	NULL
well	NULL
as	NULL
IL-4-induced	NULL
proliferation	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
48-50	NULL
,	NULL
54-56	NULL
)	NULL
,	NULL
thereby	NULL
suggesting	NULL
that	NULL
one	NULL
major	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
IxB/NE-	NULL
«	NULL
B/Rel	NULL
system	NULL
regulates	NULL
cytokine	NULL
receptor	NULL
capacitation	NULL
is	NULL
mediated	NULL
through	NULL
changes	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
nuclear	NULL
Stat5	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
W.	NULL
Armistead	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
B.	NULL
Enerson	NULL
,	NULL
and	NULL
S.	NULL
McCarthy	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
;	NULL
J.	NULL
Zamorano	NULL
,	NULL
M.	NULL
Rojas	NULL
,	NULL
and	NULL
S.	NULL
Goenka	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
;	NULL
Immunex	NULL
(	NULL
Seat-tle	NULL
,	NULL
WA	NULL
)	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
for	NULL
cDNAs	NULL
;	NULL
J	NULL
.	NULL

Price	NULL
and	NULL
D.	NULL
McFarland	NULL
for	NULL
expert	NULL
flow	NULL
cytometry	NULL
through	NULL
the	NULL
Vanderbilt	NULL
Cancer	NULL
Center	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
FACS	NULL
cores	NULL
;	NULL
and	NULL
the	NULL
Vanderbilt	NULL
Ingram	NULL
Cancer	NULL
Center	NULL
and	NULL
Diabetes	NULL
Research	NULL
and	NULL
Training	NULL
Center	NULL
for	NULL
Tissue	NULL
Culture	NULL
,	NULL
DNA	NULL
,	NULL
Molecular	NULL
Biology	NULL
and	NULL
Flow	NULL
Cytometry	NULL
core	NULL
functions	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Sher	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Coffman	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
immunity	NULL
to	NULL
parasites	NULL
by	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:385	NULL
.	NULL

2	NULL
.	NULL

Miyajima	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Kitamura	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
and	NULL
K.-i	NULL
.	NULL

Arai	NULL
.	NULL

1992	NULL
.	NULL

Cytokine	NULL
receptors	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:295	NULL
.	NULL

3	NULL
.	NULL

Nemoto	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
M.	NULL
Kondo	NULL
,	NULL
M.	NULL
Higuchi	NULL
,	NULL
S.	NULL
Satomi	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Mori	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1995	NULL
.	NULL

Differences	NULL
in	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
system	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
:	NULL
@	NULL
chain	NULL
is	NULL
required	NULL
for	NULL
formation	NULL
of	NULL
the	NULL
functional	NULL
mouse	NULL
IL-2	NULL
receptor	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:3001	NULL
.	NULL

4	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5:397	NULL
.	NULL

5	NULL
.	NULL

Theze	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
M.	NULL
Alzari	NULL
,	NULL
and	NULL
J.	NULL
Bertoglio	NULL
.	NULL

1996	NULL
.	NULL

Interleukin	NULL
2	NULL
and	NULL
its	NULL
receptors	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:481	NULL
.	NULL

6	NULL
.	NULL

Hu-Li	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
M.	NULL
Shevach	NULL
,	NULL
J.	NULL
Mizuguchi	NULL
,	NULL
J.	NULL
Ohara	NULL
,	NULL
T.	NULL
Mosmann	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1987	NULL
.	NULL

B	NULL
cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
(	NULL
interleukin	NULL
4	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
stimulant	NULL
for	NULL
normal	NULL
resting	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:157	NULL
.	NULL

7	NULL
.	NULL

Lichtman	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
E.	NULL
A.	NULL
Kurt-Jones	NULL
,	NULL
and	NULL
A.	NULL
K.	NULL
Abbas	NULL
.	NULL

1987	NULL
.	NULL

B	NULL
cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
and	NULL
interleukin	NULL
2	NULL
is	NULL
the	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
some	NULL
helper	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:824	NULL
.	NULL

8	NULL
.	NULL

Ohara	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1988	NULL
.	NULL

Up-regulation	NULL
of	NULL
interleukin	NULL
4/B-cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
receptor	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8221	NULL
.	NULL

9	NULL
.	NULL

Renz	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Domenico	NULL
,	NULL
and	NULL
E.	NULL
W.	NULL
Gelfand	NULL
.	NULL

1991	NULL
.	NULL

IL-4-dependent	NULL
up-regulation	NULL
of	NULL
IL-4	NULL
receptor	NULL
expression	NULL
in	NULL
murine	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:2240	NULL
.	NULL

10	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
W.	NULL
Shi	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Minami	NULL
,	NULL
S.-I	NULL
.	NULL

Kashiwamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Kira	NULL
.	NULL

1996	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signaling	NULL
.	NULL

Nature	NULL
380:627	NULL
.	NULL

11	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
S.	NULL
T.	NULL
Smiley	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
4:313	NULL
.	NULL

12	NULL
.	NULL

Hattori	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Okazaki	NULL
,	NULL
Y.	NULL
Ishida	NULL
,	NULL
M.	NULL
Onuma	NULL
,	NULL
S.	NULL
Kano	NULL
,	NULL
T.	NULL
Honjo	NULL
,	NULL
and	NULL
N.	NULL
Minato	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
murine	NULL
IL-2	NULL
receptor	NULL
-chain	NULL
on	NULL
thymic	NULL
and	NULL
splenic	NULL
lymphocyte	NULL
subpopulations	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
IL-2-induced	NULL
proliferative	NULL
response	NULL
in	NULL
human	NULL
IL-2	NULL
receptor	NULL
a-chain	NULL
transgenic	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3809	NULL
.	NULL

13	NULL
.	NULL

Asano	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Ishida	NULL
,	NULL
H.	NULL
Sabe	NULL
,	NULL
M.	NULL
Kondo	NULL
,	NULL
K.	NULL
Sugamura	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1994	NULL
.	NULL

IL-2	NULL
can	NULL
support	NULL
growth	NULL
of	NULL
CD8*	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
CD4*	NULL
T	NULL
cells	NULL
of	NULL
human	NULL
IL-2	NULL
receptor	NULL
-chain	NULL
transgenic	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5373	NULL
.	NULL

14	NULL
.	NULL

Nelson	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
J.	NULL
D.	NULL
Lord	NULL
,	NULL
and	NULL
P.	NULL
D.	NULL
Greenberg	NULL
.	NULL

1994	NULL
.	NULL

Cytoplasmic	NULL
domains	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
B	NULL
and	NULL
-y	NULL
chains	NULL
mediate	NULL
the	NULL
signal	NULL
for	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Nature	NULL
369:333	NULL
.	NULL

15	NULL
.	NULL

Moreau	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
P.	NULL
Chastagner	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
M.	NULL
Kondo	NULL
,	NULL
K.	NULL
Sugamura	NULL
,	NULL
and	NULL
J.	NULL
Theze	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
the	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
B	NULL
lymphocytes	NULL
by	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:3401	NULL
.	NULL

16	NULL
.	NULL

Chiodetti	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
competence	NULL
to	NULL
respond	NULL
to	NULL
IL-4	NULL
by	NULL
CD4*	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
clones	NULL
requires	NULL
costimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149	NULL
;	NULL
901	NULL
.	NULL

17	NULL
.	NULL

Huang	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1998	NULL
.	NULL

Impaired	NULL
interleukin	NULL
4	NULL
signaling	NULL
in	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1305	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
2226	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

Zhu	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Huang	NULL
,	NULL
L.	NULL
Guo	NULL
,	NULL
T.	NULL
Stonehouse	NULL
,	NULL
C.	NULL
J.	NULL
Watson	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

2000	NULL
.	NULL

Transient	NULL
inhibition	NULL
of	NULL
interleukin	NULL
4	NULL
signaling	NULL
by	NULL
T	NULL
cell	NULL
receptor	NULL
ligation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

192:1125	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
May	NULL
,	NULL
and	NULL
E.	NULL
B.	NULL
Kopp	NULL
.	NULL

1998	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
ref	NULL
proteins	NULL
:	NULL
evolutionary	NULL
conserved	NULL
mediators	NULL
of	NULL
immune	NULL
responses	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:225	NULL
.	NULL

Boothby	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
L.	NULL
Mora	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
J.	NULL
Brockman	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1997	NULL
.	NULL

Perturbation	NULL
of	NULL
the	NULL
T	NULL
lymphocyte	NULL
lineage	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
NF-kB	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1897	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809	NULL
.	NULL

Doi	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
T.	NULL
Takahashi	NULL
,	NULL
O.	NULL
Taguchi	NULL
,	NULL
T.	NULL
Azuma	NULL
,	NULL
and	NULL
Y.	NULL
Obata	NULL
.	NULL

1997	NULL
.	NULL

NF-kB	NULL
RelA-deficient	NULL
lymphocytes	NULL
:	NULL
normal	NULL
development	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
impaired	NULL
production	NULL
of	NULL
IgA	NULL
and	NULL
IgG1	NULL
and	NULL
reduced	NULL
proliferative	NULL
responses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:953	NULL
.	NULL

Paul	NULL
,	NULL
W.	NULL
E.	NULL
1991	NULL
.	NULL

Interleukin-4	NULL
:	NULL
a	NULL
prototypic	NULL
immunoregulatory	NULL
lymphokine	NULL
.	NULL

Blood	NULL
77:1589	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
Zamorano	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
growth	NULL
,	NULL
and	NULL
cell	NULL
survival	NULL
by	NULL
IL-4	NULL
:	NULL
contribution	NULL
of	NULL
multiple	NULL
signaling	NULL
pathways	NULL
.	NULL

Cell	NULL
.	NULL

Res	NULL
.	NULL

8:1	NULL
.	NULL

Youn	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Chen	NULL
,	NULL
J.	NULL
Goenka	NULL
,	NULL
M.	NULL
A.	NULL
Aronica	NULL
,	NULL
A.	NULL
L.	NULL
Mora	NULL
,	NULL
V.	NULL
Correa	NULL
,	NULL
J.	NULL
R.	NULL
Sheller	NULL
,	NULL
and	NULL
M.	NULL
Boothby	NULL
.	NULL

1998	NULL
.	NULL

In	NULL
vivo	NULL
function	NULL
of	NULL
an	NULL
IL-2R/IL-4Ra	NULL
cytokine	NULL
receptor	NULL
chimera	NULL
potentiates	NULL
allergic	NULL
airway	NULL
discase	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:1803	NULL
.	NULL

Pine	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Canova	NULL
,	NULL
and	NULL
C.	NULL
Schindler	NULL
.	NULL

1994	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
p91	NULL
binds	NULL
to	NULL
a	NULL
single	NULL
element	NULL
in	NULL
the	NULL
ISGF2/IRP-1	NULL
promoter	NULL
to	NULL
mediate	NULL
induction	NULL
by	NULL
IFN	NULL
a	NULL
and	NULL
IFN	NULL
7	NULL
,	NULL
and	NULL
is	NULL
likely	NULL
to	NULL
autoregulate	NULL
the	NULL
p91	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:158	NULL
.	NULL

Wang	NULL
,	NULL
D.-Z	NULL
.	NULL

,	NULL
A.	NULL
L.	NULL
Cherrington	NULL
,	NULL
B.	NULL
Famakin-Mosuro	NULL
,	NULL
and	NULL
M.	NULL
Boothby	NULL
.	NULL

1996	NULL
.	NULL

Independent	NULL
pathways	NULL
for	NULL
de-repression	NULL
of	NULL
the	NULL
mouse	NULL
Ig	NULL
heavy	NULL
chain	NULL
germ-line	NULL
e	NULL
promoter	NULL
:	NULL
an	NULL
IL-4	NULL
NAFP/NF-IL-4	NULL
site	NULL
as	NULL
a	NULL
context-dependent	NULL
negative	NULL
element	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

8:977	NULL
.	NULL

Hassouna	NULL
,	NULL
N.	NULL
,	NULL
B.	NULL
Michot	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Bachellerie	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
mouse	NULL
288	NULL
rRNA	NULL
gene	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
process	NULL
of	NULL
size	NULL
increase	NULL
of	NULL
the	NULL
large	NULL
subunit	NULL
rRNA	NULL
in	NULL
higher	NULL
eukaryotes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:3563	NULL
.	NULL

Harding	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
J.	NULL
McArthur	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
Raulet	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1995	NULL
.	NULL

CD28-mediated	NULL
signalling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T-cell	NULL
clones	NULL
.	NULL

Nature	NULL
356:607	NULL
.	NULL

Aune	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
A.	NULL
L.	NULL
Mora	NULL
,	NULL
S.	NULL
Kim	NULL
,	NULL
M.	NULL
Boothby	NULL
,	NULL
and	NULL
A.	NULL
H.	NULL
Lichtman	NULL
.	NULL

1999	NULL
.	NULL

Costimulation	NULL
reverses	NULL
the	NULL
defect	NULL
in	NULL
IL-2	NULL
but	NULL
not	NULL
effector	NULL
cytokine	NULL
production	NULL
by	NULL
T	NULL
cells	NULL
with	NULL
impaired	NULL
IxBa	NULL
degradation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:5805	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
K.	NULL
Shimoda	NULL
,	NULL
W.	NULL
Thierfelder	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
A.	NULL
Kim	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
A.	NULL
Keegan	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
mouse	NULL
and	NULL
human	NULL
Stat6	NULL
,	NULL
proteins	NULL
that	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
IL-3	NULL
but	NULL
are	NULL
not	NULL
required	NULL
for	NULL
mitogenesis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3336	NULL
.	NULL

Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
L.	NULL
J.	NULL
McReynolds	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
L-H.	NULL
Wang	NULL
,	NULL
E.	NULL
Garfein	NULL
,	NULL
P.	NULL
Rothman	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1996	NULL
.	NULL

Growth	NULL
and	NULL
gene	NULL
expression	NULL
are	NULL
predominantly	NULL
controlled	NULL
by	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
receptor	NULL
.	NULL

Immunity	NULL
4:123	NULL
.	NULL

Casey	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
M.	NULL
Boothby	NULL
.	NULL

1992	NULL
.	NULL

IL-4	NULL
induces	NULL
IL-2	NULL
receptor	NULL
p75	NULL
B-chain	NULL
gene	NULL
expression	NULL
and	NULL
IL-2-dependent	NULL
proliferation	NULL
in	NULL
mouse	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:3418	NULL
.	NULL

Duyao	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
A.	NULL
Buckler	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1990	NULL
.	NULL

Interaction	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
with	NULL
a	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
c-myc	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4727	NULL
.	NULL

Pemis	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Witthuhn	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
E.	NULL
Garfein	NULL
,	NULL
J.	NULL
N.	NULL
Thle	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
4	NULL
signals	NULL
through	NULL
two	NULL
related	NULL
pathways	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7971	NULL
.	NULL

Nelms	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
J.	NULL
Zamorano	NULL
,	NULL
J.	NULL
J.	NULL
Ryan	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
IL-4	NULL
receptor	NULL
:	NULL
signaling	NULL
mechanisms	NULL
and	NULL
biologic	NULL
functions	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:4506	NULL
.	NULL

O	NULL
'	NULL
Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Jaks	NULL
,	NULL
STATs	NULL
,	NULL
cytokine	NULL
signal	NULL
transduction	NULL
,	NULL
and	NULL
immunoregu-lation	NULL
:	NULL
are	NULL
we	NULL
there	NULL
yet	NULL
?	NULL

Immunity	NULL
7:1	NULL
.	NULL

Wang	NULL
,	NULL
L	NULL
.M	NULL
.	NULL

,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
M.	NULL
Frankel	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Pierce	NULL
.	NULL

1995	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
the	NULL
IL-4	NULL
and	NULL
insulin	NULL
receptor	NULL
families	NULL
.	NULL

Stem	NULL
Cells	NULL
13:360	NULL
.	NULL

Wang	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
G.	NULL
Lienhard	NULL
,	NULL
S.	NULL
Pacini	NULL
,	NULL
J.	NULL
Gutkind	NULL
,	NULL
M.	NULL
G.	NULL
Myers	NULL
,	NULL
Jr.	NULL
,	NULL
X.-J	NULL
.	NULL

Sun	NULL
,	NULL
M.	NULL
F.	NULL
White	NULL
,	NULL
S.	NULL
A.	NULL
Aaronson	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Common	NULL
elements	NULL
in	NULL
interleukin	NULL
4	NULL
and	NULL
insulin	NULL
signaling	NULL
pathways	NULL
in	NULL
factor-dependent	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:4032	NULL
.	NULL

Wang	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
M.	NULL
G.	NULL
Myers	NULL
,	NULL
Jr.	NULL
,	NULL
X.	NULL
J	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
A.	NULL
Aaronson	NULL
,	NULL
M.	NULL
White	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Pierce	NULL
.	NULL

1993	NULL
.	NULL

IRS-1	NULL
:	NULL
essential	NULL
for	NULL
insulin-	NULL
and	NULL
IL-4-stimulated	NULL
mitogenesis	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Science	NULL
261:1591	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
M.	NULL
White	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
IL-4	NULL
receptor	NULL
region	NULL
containing	NULL
an	NULL
insulin	NULL
receptor	NULL
motif	NULL
is	NULL
important	NULL
for	NULL
IL-4-mediated	NULL
IRS-1	NULL
phosphorylation	NULL
and	NULL
cell	NULL
growth	NULL
.	NULL

Cell	NULL
76:811	NULL
.	NULL

Welham	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
H.	NULL
Bone	NULL
,	NULL
M.	NULL
Levings	NULL
,	NULL
L.	NULL
Learmonth	NULL
,	NULL
L.	NULL
M.	NULL
Wang	NULL
,	NULL
K.	NULL
B.	NULL
Leslie	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Schrader	NULL
.	NULL

1997	NULL
.	NULL

Insulin	NULL
receptor	NULL
substrate-2	NULL
is	NULL
the	NULL
major	NULL
170-kDa	NULL
protein	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
in	NULL
murine	NULL
lymphohemopoictic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:1377.	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
C.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.L	NULL
.	NULL

McKnight	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
265:1701	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
van	NULL
Deursen	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignali	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
AND	NULL
LYMPHOKINE-DEPENDENT	NULL
PROLIFERATION	NULL
OF	NULL
T	NULL
LYMPHOID	NULL
CELLS	NULL
Kaplan	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Daniel	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
and	NULL
M.	NULL
Grusby	NULL
.	NULL

1998	NULL
.	NULL

Stat	NULL
proteins	NULL
control	NULL
lymphocyte	NULL
proliferation	NULL
by	NULL
regulating	NULL
p27Kip1	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
:	NULL
1996	NULL
.	NULL

Lischke	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Moriggl	NULL
,	NULL
S.	NULL
Brandlein	NULL
,	NULL
S.	NULL
Berchtold	NULL
,	NULL
W.	NULL
Kammer	NULL
,	NULL
W.	NULL
Sebald	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
and	NULL
K.	NULL
Friedrich	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
interleukin-4	NULL
receptor	NULL
activates	NULL
STATS5	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
relies	NULL
upon	NULL
common	NULL
y-chain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:31222	NULL
.	NULL

Friedrich	NULL
,	NULL
K.	NULL
,	NULL
W.	NULL
Kammer	NULL
,	NULL
I.	NULL
Erhardt	NULL
,	NULL
S.	NULL
Brandlein	NULL
,	NULL
W.	NULL
Sebald	NULL
,	NULL
and	NULL
R.	NULL
Moriggl	NULL
.	NULL

1999	NULL
.	NULL

Activation	NULL
of	NULL
StatS	NULL
by	NULL
IL-4	NULL
relies	NULL
on	NULL
Janus	NULL
kinase	NULL
function	NULL
but	NULL
not	NULL
on	NULL
receptor	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
and	NULL
can	NULL
contribute	NULL
to	NULL
both	NULL
cell	NULL
proliferation	NULL
and	NULL
gene	NULL
regulation	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

11:1283	NULL
.	NULL

Moriggl	NULL
,	NULL
R.	NULL
,	NULL
V.	NULL
Sexl	NULL
,	NULL
R.	NULL
Pickoriz	NULL
,	NULL
D.	NULL
Topham	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thle	NULL
.	NULL

1999	NULL
.	NULL

Stat§	NULL
activation	NULL
is	NULL
uniquely	NULL
associated	NULL
with	NULL
cytokine	NULL
signaling	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
11:225	NULL
.	NULL

Yamashita	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Katsumata	NULL
,	NULL
M.	NULL
Iwashima	NULL
,	NULL
M.	NULL
Kimura	NULL
,	NULL
C.	NULL
Shimizu	NULL
,	NULL
T.	NULL
Kamata	NULL
,	NULL
T.	NULL
Shin	NULL
,	NULL
N.	NULL
Seki	NULL
,	NULL
S.	NULL
Suzuki	NULL
,	NULL
M.	NULL
Taniguchi	NULL
,	NULL
and	NULL
T.	NULL
Nakayama	NULL
.	NULL

2000	NULL
.	NULL

T	NULL
cell	NULL
re-ceptor-induced	NULL
calcineurin	NULL
activation	NULL
regulates	NULL
T	NULL
helper	NULL
type	NULL
2	NULL
cell	NULL
development	NULL
by	NULL
modifying	NULL
the	NULL
interleukin	NULL
4	NULL
receptor	NULL
signaling	NULL
complex	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

191	NULL
:	NULL
1869	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
and	NULL
O.	NULL
Silvennoinen	NULL
.	NULL

1995	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:369	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
M.	NULL
Higuchi	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Sharing	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
-y	NULL
chain	NULL
between	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Science	NULL
262:1874	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
P.	NULL
Leland	NULL
,	NULL
M.	NULL
C.	NULL
Friedmann	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
R.	NULL
K.	NULL
Puri	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

Science	NULL
262:1880	NULL
.	NULL

Moriggl	NULL
,	NULL
R.	NULL
,	NULL
D.	NULL
J.	NULL
Topham	NULL
,	NULL
S.	NULL
Teglund	NULL
,	NULL
V.	NULL
Sexl	NULL
,	NULL
C.	NULL
McKay	NULL
,	NULL
D.	NULL
Wang	NULL
,	NULL
A.	NULL
Hoffmeyer	NULL
,	NULL
J.	NULL
van	NULL
Deursan	NULL
,	NULL
M.	NULL
Sangster	NULL
,	NULL
K.	NULL
Bunting	NULL
,	NULL
G.	NULL
C.	NULL
Grosveld	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thie	NULL
.	NULL

1999	NULL
.	NULL

Stat5	NULL
is	NULL
required	NULL
for	NULL
IL-2-induced	NULL
cell	NULL
cycle	NULL
progression	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
10:249	NULL
.	NULL

Lord	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B.	NULL
Mcintosh	NULL
,	NULL
P.	NULL
Greenberg	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Nelson	NULL
.	NULL

2000	NULL
.	NULL

The	NULL
IL-2	NULL
receptor	NULL
promotes	NULL
lymphocyte	NULL
proliferation	NULL
and	NULL
induction	NULL
of	NULL
the	NULL
c-myc	NULL
,	NULL
be/-2	NULL
,	NULL
and	NULL
bel-x	NULL
genes	NULL
through	NULL
the	NULL
trans-activation	NULL
domain	NULL
of	NULL
StatS	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:2533	NULL
.	NULL

Friedmann	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
T.	NULL
Migone	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1996	NULL
.	NULL

Different	NULL
interleukin	NULL
2	NULL
receptor	NULL
B-chain	NULL
tyrosines	NULL
couple	NULL
to	NULL
at	NULL
least	NULL
two	NULL
signaling	NULL
pathways	NULL
and	NULL
synergistically	NULL
mediate	NULL
interleukin	NULL
2-induced	NULL
proliferation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:2077	NULL
.	NULL

Rabin	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
J.	NULL
Mond	NULL
,	NULL
J.	NULL
Ohara	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1986	NULL
.	NULL

B	NULL
cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
(	NULL
BSF-1	NULL
)	NULL
prepares	NULL
resting	NULL
B	NULL
cells	NULL
to	NULL
enter	NULL
S	NULL
phase	NULL
in	NULL
response	NULL
to	NULL
anti-IgM	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164:517	NULL
.	NULL

Venkataraman	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Leung	NULL
,	NULL
A.	NULL
Salvekar	NULL
,	NULL
H.	NULL
Mano	NULL
,	NULL
and	NULL
U.	NULL
Schindler	NULL
.	NULL

2000	NULL
.	NULL

Repression	NULL
of	NULL
IL-4-induced	NULL
gene	NULL
expression	NULL
by	NULL
IFN-y	NULL
requires	NULL
Statl	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:4053	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
Minn	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

Growth	NULL
factors	NULL
can	NULL
enhance	NULL
lymphocyte	NULL
survival	NULL
without	NULL
committing	NULL
the	NULL
cell	NULL
to	NULL
undergo	NULL
cell	NULL
division	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:5491	NULL
.	NULL

Vella	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Teague	NULL
,	NULL
J.	NULL
Thle	NULL
,	NULL
J.	NULL
Kappler	NULL
,	NULL
and	NULL
P.	NULL
Marrack	NULL
.	NULL

1997	NULL
.	NULL

Interleukin	NULL
4	NULL
(	NULL
IL-4	NULL
)	NULL
or	NULL
IL-7	NULL
prevents	NULL
the	NULL
death	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
:	NULL
Stat6	NULL
is	NULL
probably	NULL
not	NULL
required	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:325	NULL
.	NULL

Aronica	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Goenka	NULL
,	NULL
and	NULL
M.	NULL
Boothby	NULL
.	NULL

2000	NULL
.	NULL

IL-4-dependent	NULL
induction	NULL
of	NULL
Bcl-2	NULL
and	NULL
Bcl-XL	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
through	NULL
a	NULL
Staté-	NULL
and	NULL
PI-3	NULL
kinase-independent	NULL
pathway	NULL
.	NULL

Cytokine	NULL
12:578	NULL
.	NULL

Foote	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
R.	NULL
Howard	NULL
,	NULL
A.	NULL
Marshak-Rothstein	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Rothstein	NULL
.	NULL

1996	NULL
.	NULL

IL-4	NULL
induces	NULL
Fas	NULL
resistance	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2749	NULL
.	NULL

Zamorano	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Y.	NULL
Wang	NULL
,	NULL
R.	NULL
Wang	NULL
,	NULL
Y.	NULL
Shi	NULL
,	NULL
G.	NULL
Longmore	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
growth	NULL
by	NULL
IL-2	NULL
:	NULL
role	NULL
of	NULL
Stat5	NULL
in	NULL
protection	NULL
from	NULL
apoptosis	NULL
but	NULL
not	NULL
in	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3502.	NULL
.	NULL

Delphin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-4	NULL
responsive	NULL
region	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
germ-line	NULL
e	NULL
promoter	NULL
:	NULL
regulation	NULL
by	NULL
NF-IL4	NULL
,	NULL
a	NULL
C/EBP	NULL
family	NULL
member	NULL
,	NULL
and	NULL
NF-kB	NULL
p50	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:181	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
P.	NULL
Zelazowski	NULL
,	NULL
F.	NULL
Rosas	NULL
,	NULL
M.	NULL
Kehry	NULL
,	NULL
M.	NULL
Tian	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Sha	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
cells	NULL
from	NULL
p5O/NF-KB1	NULL
knockout	NULL
mice	NULL
have	NULL
selective	NULL
defects	NULL
in	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
germ-line	NULL
C	NULL
;	NULL
,	NULL
transcription	NULL
,	NULL
and	NULL
Ig	NULL
class	NULL
switch-ing	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:183	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
N.	NULL
Halden	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1989	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
x	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244:466	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
M.	NULL
Sickievitz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
interleukin	NULL
2	NULL
receptor	NULL
expression	NULL
.	NULL

Science	NULL
244:457	NULL
.	NULL

Kontgen	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
Grumont	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
D.	NULL
Tarlinton	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1995	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
c-re/	NULL
proto-oncogene	NULL
exhibit	NULL
defects	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
,	NULL
humoral	NULL
immunity	NULL
,	NULL
and	NULL
interleukin-2	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1965	NULL
.	NULL

Nosaka	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
van	NULL
Deursen	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
W.	NULL
Thierfelder	NULL
,	NULL
B.	NULL
Wittuhn	NULL
,	NULL
A.	NULL
McMickle	NULL
,	NULL
P.	NULL
Doherty	NULL
,	NULL
G.	NULL
C.	NULL
Grosveld	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thle	NULL
.	NULL

1995	NULL
.	NULL

Defective	NULL
lymphoid	NULL
development	NULL
in	NULL
mice	NULL
lacking	NULL
Jak3	NULL
.	NULL

Science	NULL
270:800	NULL
.	NULL

Thomis	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Gurniak	NULL
,	NULL
E.	NULL
Tivol	NULL
,	NULL
A.	NULL
Sharpe	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Berg	NULL
.	NULL

1995	NULL
.	NULL

Defects	NULL
in	NULL
B	NULL
lymphocyte	NULL
maturation	NULL
and	NULL
T	NULL
lymphocyte	NULL
activation	NULL
in	NULL
mice	NULL
lacking	NULL
Jak3	NULL
.	NULL

Science	NULL
270:794	NULL
.	NULL

Oakes	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
F.	NULL
Candotti	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
Y.-Q	NULL
.	NULL

Chen	NULL
,	NULL
J.	NULL
J.	NULL
Ryan	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
L.	NULL
Notarangelo	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
via	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

IL-2	NULL
and	NULL
IL-4	NULL
in	NULL
Jak3-deficient	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
lymphocytes	NULL
:	NULL
Jak3-dependent	NULL
and	NULL
independent	NULL
pathways	NULL
.	NULL

Immunity	NULL
5:605	NULL
.	NULL

Chen	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
B.	NULL
Patel	NULL
,	NULL
L.-M.	NULL
Wang	NULL
,	NULL
M.	NULL
Frankel	NULL
,	NULL
N.	NULL
Ellmore	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
W.	NULL
LaRochelle	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Pierce	NULL
.	NULL

1997	NULL
.	NULL

Jak1	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
interleukin-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
insulin	NULL
receptor	NULL
substrate	NULL
and	NULL
Stat6	NULL
signaling	NULL
molecules	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:6556	NULL
.	NULL

Wang	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
J.	NULL
Zamorano	NULL
,	NULL
J.	NULL
Yoerkic	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
insulin	NULL
receptor	NULL
substrate	NULL
is	NULL
dependent	NULL
on	NULL
Jak1	NULL
expression	NULL
in	NULL
human	NULL
fibrosarcoma	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:1037	NULL
.	NULL

Rodig	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
M.	NULL
Meraz	NULL
,	NULL
J	NULL
.	NULL

White	NULL
,	NULL
P.	NULL
Lampe	NULL
,	NULL
J.	NULL
Riley	NULL
,	NULL
C.	NULL
Arthur	NULL
,	NULL
K.	NULL
King	NULL
,	NULL
K.	NULL
Shechan	NULL
,	NULL
L.	NULL
Yin	NULL
,	NULL
D.	NULL
Pennica	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
Jak1	NULL
gene	NULL
demonstrates	NULL
obligate	NULL
and	NULL
non-redundant	NULL
roles	NULL
of	NULL
the	NULL
Jaks	NULL
in	NULL
cytokine-induced	NULL
biologic	NULL
responses	NULL
.	NULL

Cell	NULL
93:373	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
K.	NULL
Saijo	NULL
,	NULL
T.	NULL
Takahashi	NULL
,	NULL
M.	NULL
Osawa	NULL
,	NULL
H.	NULL
Arase	NULL
,	NULL
N.	NULL
Hirayama	NULL
,	NULL
K.	NULL
Miyake	NULL
,	NULL
H.	NULL
Nakauchi	NULL
,	NULL
T.	NULL
Shirasawa	NULL
,	NULL
and	NULL
T.	NULL
Saito	NULL
.	NULL

1995	NULL
.	NULL

Developmental	NULL
defects	NULL
of	NULL
lymphoid	NULL
cells	NULL
in	NULL
Jak3	NULL
kinase-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
3:771	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

2227	NULL
Thomis	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Berg	NULL
.	NULL

1997	NULL
.	NULL

Peripheral	NULL
expression	NULL
of	NULL
Jak3	NULL
is	NULL
required	NULL
to	NULL
maintain	NULL
T	NULL
lymphocyte	NULL
function	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:197	NULL
.	NULL

Sohn	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
K.	NULL
Forbush	NULL
,	NULL
N.	NULL
Nguyen	NULL
,	NULL
B.	NULL
Witthubhn	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
J.	NULL
N.	NULL
Thie	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Perlmutter	NULL
.	NULL

1998	NULL
.	NULL

Requirement	NULL
for	NULL
Jak3	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
:	NULL
its	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
homeostasis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2130	NULL
.	NULL

Nakajima	NULL
,	NULL
H.	NULL
,	NULL
X.	NULL
W.	NULL
Liu	NULL
,	NULL
A.	NULL
Wynshaw-Boris	NULL
,	NULL
L.	NULL
Rosenthal	NULL
,	NULL
K.	NULL
Imada	NULL
,	NULL
D.	NULL
Finbloom	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1997	NULL
.	NULL

An	NULL
indirect	NULL
effect	NULL
of	NULL
StatSa	NULL
in	NULL
IL-2-induced	NULL
proliferation	NULL
:	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
StatSa	NULL
in	NULL
IL-2-mediated	NULL
IL-2	NULL
receptor	NULL
@	NULL
chain	NULL
expression	NULL
.	NULL

Immunity	NULL
7:691	NULL
.	NULL

Liu	NULL
,	NULL
X.	NULL
,	NULL
G.	NULL
Robinson	NULL
,	NULL
K.	NULL
Wagner	NULL
,	NULL
L.	NULL
Garret	NULL
,	NULL
A.	NULL
Wynshaw-Boris	NULL
,	NULL
and	NULL
L.	NULL
Hennighausen	NULL
.	NULL

1997	NULL
.	NULL

StatSa	NULL
is	NULL
mandatory	NULL
for	NULL
adult	NULL
mammary	NULL
gland	NULL
development	NULL
and	NULL
lactogenesis	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:179	NULL
.	NULL

Udy	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
R.	NULL
Towers	NULL
,	NULL
R.	NULL
Snell	NULL
,	NULL
R.	NULL
Wilkins	NULL
,	NULL
S.-H.	NULL
Park	NULL
,	NULL
P.	NULL
A.	NULL
Ram	NULL
,	NULL
D.	NULL
Waxman	NULL
,	NULL
and	NULL
H.	NULL
W.	NULL
Davey	NULL
.	NULL

1997	NULL
.	NULL

Requirement	NULL
of	NULL
StatSb	NULL
for	NULL
sexual	NULL
dimorphism	NULL
of	NULL
body	NULL
growth	NULL
rates	NULL
and	NULL
liver	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:7239	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

